Signed agreement exchanged between leaders of Kody Technolab Limited, Falcon Tech Robotics & Sccore AI Tech in Dubai, UAE

The engagement is structured for execution over the three-year term of the Agreement, with manufacturing and supply of Medigo units to commence in H1 of FY 2026-27 and continuing across the term. The Agreement is underpinned by a binding minimum purchase framework structured across biannual commercial periods, providing Kody Technolab Limited with structured commercial visibility through the term.

The Agreement positions Kody Technolab at the intersection of one of healthcare’s largest unmet needs and one of its fastest-growing markets. According to the WHO and World Bank, an estimated 4.5 billion people, over half the world’s population, lack full access to essential health services. Against this backdrop, leading industry research projects the global preventive healthcare market to grow from approximately USD 268.7 billion in 2023 to USD 585.6 billion by 2030, providing a substantial addressable market for AI-powered, autonomous healthcare screening platforms such as Medigo.

The Agreement establishes a tripartite commercial framework spanning manufacturing, distribution and worldwide deployment of Kody Technolab’s medical robotics platform. Kody Technolab will manufacture the Products on an exclusive worldwide basis. Falcon Tech Robotics LLC, Kody Technolab’s UAE-based joint venture, will undertake exclusive global distribution and commercial coordination. Sccore AI Tech Diagnostic Limited, UAE, will deploy and commercialize the Products across international markets.

Medigo AI-powered healthcare screening robot developed by Kody Technolab Limited

The Medigo Range

The Medigo range comprises four AI-powered healthcare screening robots, each engineered to deliver clinical-grade preventive screening within minutes, without dependence on specialised medical staff:

• Medigo Static - a stationary, autonomous health-screening robot designed for fixed deployments in primary health centres, corporate campuses, public institutions, and other high-footfall locations.

• Medigo Kids - a paediatric screening robot purpose-built for children’s health check-ups in schools, pediatric clinics and community child-health programmes.

• Medigo Women - a women’s health screening robot tailored for gender-specific preventive check-ups across maternal, reproductive and general wellness parameters.

• Medigo Mobile - a moving / robotic “health screening ATM” engineered for on-demand and last-mile deployments across transit hubs, rural outreach routes and high-footfall public spaces.

Each unit is built to screen for a broad spectrum of conditions across metabolic, cardiovascular, infectious, sensory and mental health categories, generate a consolidated report within minutes in the patient’s preferred language, and feed real-time anonymised data into institutional and government health dashboards.

The engagement represents a significant milestone in Kody Technolab’s strategy to scale its healthcare robotics business globally and strengthens the Company’s strategic presence in the UAE and other international markets. By combining Kody Technolab’s engineering platform with Falcon’s regional reach and Sccore’s deployment capabilities, the tripartite structure is designed to deliver Medigo-led screening infrastructure at scale across multiple geographies, reinforcing Kody Technolab’s positioning as a category-defining player in AI-powered healthcare robotics.

The Board believes this engagement marks a meaningful step in Kody Technolab’s international growth trajectory and reflects the strong commercial pull for the Company’s medical robotics platform.

Management Commentary

“This Agreement is a defining moment in our journey to take Kody Technolab’s healthcare robotics platform to global scale. The Medigo range has been engineered to address real screening needs across diverse populations, demographics and care settings, and the tripartite structure of this Agreement spanning exclusive worldwide manufacturing, global distribution through our UAE joint venture, and on-ground deployment by Sccore, gives us a powerful, integrated route to international markets. We see this as the start of a long-term, multi-geography deployment of our medical robotics platform, and we are committed to delivering at the quality, scale and pace that this opportunity demands,” Manav Subhashchandra Patel, Managing Director, Kody Technolab Limited.

“Sccore is proud to partner with Kody Technolab and Falcon Tech Robotics in bringing the Medigo platform to global markets. Access to timely, affordable preventive screening remains one of the most critical unmet needs of our time, and the Medigo range, engineered for clinical-grade screening, multilingual interaction and real-time data delivery, gives us a uniquely scalable platform to meet that need. We look forward to deploying Medigo at scale across diverse healthcare environments worldwide, in long-term partnership with Kody Technolab and Falcon,” Prashant Sawant, Chairman & MD, Sccore AI Tech Diagnostic Limited.

About Kody Technolab Limited

Kody Technolab Ltd is a leading deep tech company specializing in autonomous robotics solutions and AI-driven automation for commercial, retail, and industrial environments. With expertise in software engineering, autonomous navigation, and intelligent systems design, Kody Technolab Ltd develops scalable robotic platforms that power major deployments across the Middle East and Asia.

About Falcon Tech Robotics LLC

Falcon Tech Robotics is a UAE-based joint venture between Kody Technolab Ltd and Platinum Group for Businessmen Services LLC, dedicated to accelerating robotics adoption across the Middle East. The company deploys advanced AI-driven robots powered by Kody Technolab Ltd’s technology and supported by Platinum Group’s regional market presence.

About Sccore AI Tech Diagnostic Limited

Sccore AI Tech Diagnostic Limited is a UAE-based company engaged in the deployment and commercialization of AI-powered diagnostic and healthcare technology solutions across global markets.

Forward-looking Statements

This release contains forward-looking statements relating to the Company's plans, prospects, execution timelines and market estimates, which are subject to risks and uncertainties; actual results may differ materially, and the Company undertakes no obligation to publicly update any such statements.

(C) Baba Sai Kaliram Saheb ji with Fortis Mumbai team - Dr Vishal Beri, Dr S. Narayani, Ms Rinku Mavani & Dr Supriya Amey at the inauguration of Fortis Medical Centre in Ulhasnagar
 

Strategically located, the Fortis Medical Centre in Ulhasnagar has been designed as a comprehensive multi-specialty outpatient facility that brings expert medical care closer to residents of Ulhasnagar and neighboring communities. The centre offers consultations across a wide range of specialties including:

Dr. Avanish Saklani, Director-Surgical Oncology, Fortis Hospital Mulund & Kalyan (Onco Surgery)

Dr. Gurneet Singh Sawhney, Director-Stereotactic & Functional Neurosciences, Fortis Hospital Mulund (Deep Brain Stimulation & Functional Neurosurgery)

Dr. Haresh Dodeja, Director-Nephrology, Fortis Hospital Mulund & Kalyan (Renal Sciences)

Dr. Hrishikesh Salgaonkar, Consultant-Bariatric and Laparoscopic Surgery, Fortis Hospital Mulund (Bariatric & General Surgery)

Dr. Jayesh Sardhara, Director-MIS Neuro & Spine Surgery and Dr. Rushabh Chheda, Consultant-Neuro & Spine Surgery, Fortis Hospital Mulund & Kalyan (Neuro & Spine Surgery)

Dr. Priyanka Moule, Associate Consultant-HematoOncology & BMT, Fortis Hospital Mulund (Haematology)

Dr. Rachana Tataria, Consultant-Plastic & Reconstructive Surgery, Fortis Hospital Mulund (Plastic & Reconstructive Surgery)

Dr. Rakesh Lalla, Addl. Director-Neurology, Fortis Hospital Kalyan (Neurology)

Dr. Rathan Shetty, Consultant-Head & Neck Surgical Oncology, Fortis Hospital Mulund (Head & Neck Oncology)

Dr. Saurabh Patil, Senior Consultant-Urology & Uro-Oncology, Fortis Hospital Mulund (Urology)

Dr. Varun Bhatia, Consultant-Cardiology, Fortis Hospital Mulund (Cardiac Sciences)

Dr. Vikram Raut, Senior Consultant-Gastroenterology, Hepatobilliary Services, Liver Transplant, Fortis Hospital Mulund (Liver Sciences)

In addition to specialist consultations, the centre houses a dedicated 6-bed Dialysis unit to support patients requiring regular renal care and chronic disease management. The facility is further backed by Fortis Healthcare’s integrated clinical network, enabling patients to access multidisciplinary expertise and coordinated treatment pathways under one roof. Looking ahead, the centre plans to introduce oncology day-care services, strengthening access to cancer care for patients in the region.

The launch of the new Fortis Medical Centre in Ulhasnagar reflects Fortis Healthcare's continued focus on expanding its footprint beyond metropolitan centres, bringing specialist consultations, chronic disease management, and multidisciplinary clinical expertise closer to where patients live. Built on a patient-first philosophy, the centre reduces the need for long-distance travel for families while improving continuity of care and health outcomes for the community.

Speaking at the inauguration, Baba Sai Kaliram Saheb ji said, “Good health is the foundation of a happy and thriving community. In today’s fast-paced world, families often face challenges in accessing timely and specialized medical care, especially for the elderly, those living with chronic illnesses, and patients requiring regular treatment. The establishment of Fortis Medical Centre in Ulhasnagar is a meaningful step towards bringing quality healthcare closer to the people, reducing the burden of travel and making expert medical guidance more accessible. When healthcare is available within the community, it not only supports physical well-being but also provides comfort and reassurance to patients and their families during difficult times. It is heartening to see initiatives that prioritize the health and welfare of the community and contribute towards building a healthier future for all.”

The centre brings together specialists from multiple disciplines under one roof, enabling coordinated care for patients with complex and chronic health conditions. Through an integrated outpatient model, patients can access consultations, follow-up care, diagnostics coordination, and treatment planning seamlessly, improving convenience and clinical outcomes.

Dr S. Narayani, Business Head-Fortis Hospitals Maharashtra, said, “The launch of Fortis Medical Centre in Ulhasnagar marks an important step in our commitment to expanding access to quality healthcare across the city. As healthcare needs continue to evolve, it is essential to bring specialized medical expertise and comprehensive care closer to the communities we serve. This centre has been designed to provide patients with convenient access to consultations across multiple specialties, supported by a dedicated dialysis unit and a seamless transfer pathway to Fortis Hospitals in Kalyan and Mulund for advanced care when required. With plans to introduce oncology day-care services in the near future, we are building a healthcare ecosystem that not only addresses current healthcare requirements but is also equipped to meet the growing needs of the region in the years ahead.”

Beyond outpatient care, the centre is equipped to facilitate timely emergency response and patient transfers. In critical situations, patients can be rapidly referred and transferred to nearby hospitals or to Fortis Hospitals in Kalyan and Mulund, ensuring access to advanced tertiary and quaternary care whenever required. This integrated transfer network is expected to significantly enhance emergency preparedness and continuity of treatment, particularly for patients requiring specialized interventions.

Commenting on the launch, Dr Vishal Beri, Facility Director, Fortis Hospital Mulund, said, “At Fortis, our approach to healthcare is rooted in clinical excellence, evidence-based medical practices, and a strong commitment to patient-centric care. The launch of Fortis Medical Centre in Ulhasnagar enables us to extend these standards to a wider patient population by bringing experienced specialists and quality outpatient services closer to the community. By integrating local accessibility with the strengths of the broader Fortis healthcare ecosystem, we aim to ensure that patients receive timely, coordinated, and high-quality care at every stage of their healthcare journey.”

The Fortis Medical Centre is expected to play a vital role in addressing the growing healthcare needs of Ulhasnagar and surrounding areas, while further strengthening Fortis Healthcare’s mission of delivering accessible, affordable, and high-quality healthcare across India.

About Fortis Medical Centre, Ulhasnagar

Fortis Medical Centre is located at Ashirwad Hospital Road, Maratha Section 32, Opp. Bharat Gas, Nr. Shani Mandir, Ulhasnagar-4 (East) and appointments can be sought on 022 4111 4111 & www.fortishealthcare.com/location/fortis-hospital-mulund-mumbai.

About Fortis Healthcare Limited

Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics, and day care specialty facilities. Currently, the company operates 36 healthcare facilities (including JVs and O&M facilities) across 12 states and union territories. The Company’s network comprises over 6,000 operational beds (including O&M beds) and 400 diagnostics labs.

ABOUT IHH Healthcare (“IHH”)

IHH is a leading multinational healthcare provider shaping the future of care. Driven by our aspiration to Care. For Good., we unite medical excellence and innovation, pushing boundaries through our trusted brands such as Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway and Prince Court. Across 10 countries, including Malaysia, Singapore, Türkiye, India and Greater China, our 70,000-strong team delivers world-class excellence every day, within and beyond our 140 healthcare facilities, including more than 80 hospitals. Our comprehensive services span the full healthcare continuum, from primary and ambulatory to quaternary care, complemented by diagnostics, imaging, rehabilitation, telehealth and home care. In partnership with our stakeholders, IHH is advancing value-based care, building a sustainable healthcare ecosystem and creating meaningful impact, as we work towards our vision to become the world’s most trusted healthcare services network.

For more information, please visit www.ihhhealthcare.com.

Kauvery Hospital, Tirunelveli

Participants who identified healthcare as one of Tirunelveli’s defining strengths were presented with laptops, smartphones, and smartwatches by Mr. Vairamuthu, Unit Head; Dr. Lakshmanan, Medical Administrator; and Dr. S. Kavu Devi, Consultant Neuroanaesthesia and Neurocritical Care, Kauvery Hospital, Tirunelveli.

Speaking on the occasion, Mr. Vairamuthu said, “Today, Tirunelveli has access to world-class healthcare services comparable to those available in major metropolitan cities. With the presence of advanced multispecialty hospitals and highly skilled medical professionals, people from Tirunelveli no longer need to travel to Chennai, Madurai, Trivandrum, or other major cities for advanced treatments. Through this campaign, we wanted to create greater awareness about the quality and range of healthcare services available locally.”

The event was held at the newly inaugurated building of Kauvery Hospital, Tirunelveli. Spread across 2 lakh sq. ft., the state-of-the-art facility is a 300-bed hospital offering comprehensive care across 25 medical specialties.

Kapiva Ayurveda Clinic Doctors

India's chronic disease burden is no longer confined to older populations. Chronic health conditions are increasingly affecting Indians in their twenties and thirties, a generation that is not only seeking holistic alternatives but actively looking for care systems that address the root cause of their conditions, not just the symptoms. According to a 2024 survey by the Government of India, nearly half of India's population has used Ayush systems for prevention or treatment of ailments, a reflection of how deeply the system is woven into everyday health decisions. The clinics are built for someone who has started a treatment plan and not been able to stay the course, and look to address a longstanding gap in the system: inconsistent outcomes driven by the absence of structured support after the first consultation.
 

At the centre of Kapiva's clinical model is a 45 to 60 minute in-depth Ayurvedic consultation focused on identifying root causes rather than surface symptoms. By comparison, the average doctor consultation in India lasts between 5 and 10 minutes, without a clear understanding of what is driving their condition. Each patient then receives a personalised Ayurvedic treatment plan designed to fit into a real daily routine, explained in plain language, and built to be followed rather than just prescribed. The third pillar is the effortless post-care guidance: structured follow-ups at Day 7, 14, and 21, with in-built ongoing support, ensuring patients are seen through to completion, all within a single integrated patient journey that combines doctor-led diagnosis, personalised nutrition guidance, lifestyle interventions, AI-enabled diagnostics, and where appropriate, Panchkarma and Abhyangam therapies.
 

Commenting on the launch, Ameve Sharma, Founder and CEO of Kapiva said, "To offer truly comprehensive Ayurvedic care, we realised that patients require a much deeper, highly personalised approach that goes beyond just a product. Delivering that level of care requires a dedicated physical setup. In many ways, this brings Kapiva full circle. This launch was born directly from conversations with our consumers who were seeking structured support. As a customer-first brand, Kapiva Ayurveda Clinics are our way of ensuring they receive the end-to-end care they deserve."
 

Over the last ten years, Kapiva has built a stronghold in chronic wellness products that address health problems from the root cause. The clinic model extends that same philosophy into structured clinical care for chronic disease management, where consultation, product use, and follow-up are part of one continuous Ayurvedic treatment journey.
 

Kapiva Ayurveda Clinics currently operate in three locations in Bengaluru: Whitefield, HSR Layout and Sarjapur Road, with each clinic offering consultations for diabetes, heart health, chronic pain and women's health. The company plans to expand across additional Bengaluru locations before evaluating multi-city growth. The launch follows the brand’s announcement of the Kapiva Innovation Fund (KIF), a Rs. 50 crore corpus dedicated to advancing research and innovation in Ayurveda, and marks the company's broader ambition to build a holistic Ayurveda healthcare brand beyond products. 

About Kapiva
Kapiva is a homegrown science-backed Ayurveda brand on a mission to make evidence-based Ayurveda simple, modern, and accessible for everyday wellness. Backed by a dedicated R&D vertical of scientists and researchers, Kapiva develops authentic formulations using science-backed Ayurveda, standardised herbs, and high-quality ingredients. Kapiva has been a disruptor in the Ayurvedic industry by introducing innovation in product formats that can be easily integrated into people's daily routines. Kapiva has expanded globally with its wholly owned subsidiaries in the USA and Middle East, and has a strong offline presence across 50,000+ stores in India. One of India’s most trusted Ayurveda brands. 

Website: www.kapiva.in

Nikhil Kamath in conversation with Rajeev Juneja, Co-Founder and Managing Director of Mankind Pharma, and GV Prasad, Co-Chairman and CEO of Dr. Reddy's Laboratories

Together, Juneja and Prasad bring more than six decades of experience building businesses that have helped shape India's position as the pharmacy of the world. Through personal stories and industry insights, they discuss how medicines are discovered, manufactured and commercialized, why India remains a global leader in generic drugs, and what it will take for the country to emerge as a stronger innovation-driven pharmaceutical hub.

Reflecting on Mankind Pharma's journey, Rajeev Juneja shares how the company was built after its founding in 1995 with just Rs. 69,000 in capital and a strategy focused on markets often overlooked by larger players. While established pharmaceutical companies concentrated on metros and large hospitals, Mankind expanded its presence across smaller markets in Western Uttar Pradesh, Haryana and Punjab, prioritizing depth of distribution over breadth. The company differentiated itself by pricing products 40 to 60 percent below competitors, making medicines more accessible to consumers. Today, Mankind Pharma is India's fourth-largest pharmaceutical company with revenues exceeding Rs. 40,000 crore.

GV Prasad reflects on joining Dr. Reddy's Laboratories in 1990, when the company's total group revenue was less than Rs. 100 crore, and helping build it into a nearly USD 3 billion global business spanning generics, biosimilars and proprietary drug discovery. He explains the fundamental differences between generics, biologics and innovative medicines, while highlighting both India's strengths and limitations within the global pharmaceutical value chain.

A key theme of the discussion is India's next growth frontier. While India has established itself as the world's leading supplier of affordable generic medicines, Prasad notes that significantly greater value is created through innovation and the discovery of new therapies. The conversation explores emerging treatment areas such as GLP-1 drugs, the economics of drug development, and the investments required to build a globally competitive innovation ecosystem.

The episode also examines India's position relative to China. Juneja and Prasad discuss China's evolution from a low-cost manufacturing destination to a global force in pharmaceutical innovation, noting that 29 percent of all new cancer drugs are now originating from Chinese companies. The discussion highlights the importance of long-term capital, scientific talent, research infrastructure and institutional support in driving innovation-led growth.

Addressing the ongoing conversation around Active Pharmaceutical Ingredients (APIs), the two leaders offer perspectives on manufacturing resilience and supply chain competitiveness. Prasad argues that India has not lost its ability to manufacture APIs but rather faced economic challenges that shifted production elsewhere, while Juneja discusses how Indian companies are increasingly partnering with and licensing molecules from global innovators to bring advanced therapies to patients more quickly.

Beyond industry trends, the episode provides valuable insights for young professionals considering careers in pharmaceuticals. Drawing on their own experiences — from Juneja's early years as a medical representative to Prasad's journey of helping build a global pharmaceutical enterprise — both leaders emphasize the breadth of opportunities available across science, research, manufacturing, sales, entrepreneurship and healthcare innovation.

Speaking on the episode, Rajeev Juneja, said, "What you hate becomes your biggest lesson. Going to that pharmacy, sweeping, buying from the wholesale market, I hated it. But that is where I learned how the market really works."

GV Prasad added, "India is the generic pharmacy of the world. That's a good foundation. But the next frontier is finding new drugs, and I think the next ten years will be extremely interesting for Indian pharma."

Commenting on the conversation, Nikhil Kamath, said, "This conversation made clear something I hadn't quite understood before, that by volume, India is the pharmacy of the world, but by revenue, we're barely a rounding error. The real question, and these two men have spent their careers answering it, is how that changes."

The episode is available now on YouTube.

About WTF with Nikhil Kamath

WTF is a long-form conversation series hosted by entrepreneur and investor Nikhil Kamath. Each episode brings together builders, thinkers, and industry leaders for extended, unscripted conversations on business, ideas, and the texture of how things actually get done. Past guests include Elon Musk, Bill Gates, Prime Minister Narendra Modi, Rishi Sunak, and Akshata Murty. 

Kauvery Hospital launched world's advanced Pulsed Field Ablation systems to treat heart rhythm disorders

The programme introduces two of the world’s most advanced PFA technologies-Medtronic PulseSelect™ at Alwarpet and Biosense Webster Varipulse™ at Vadapalani, the latter integrated with an advanced 3D cardiac mapping system.

This is the first time that both PulseSelect™ and Varipulse™, along with a 3D mapping-integrated PFA platform, have been introduced in Tamil Nadu. This milestone further reinforces Kauvery Hospitals’ position at the forefront of innovation in cardiac electrophysiology and advanced heart rhythm care.

To mark the launch, leading international electrophysiology experts from the United States visited Chennai and collaborated with the Kauvery Hospitals team to initiate the PFA programme and support the first procedures.

Pulsed Field Ablation (PFA) is a next-generation treatment for heart rhythm disorders, particularly atrial fibrillation (AF), one of the most common cardiac arrhythmias. Unlike conventional ablation techniques that use heat (radiofrequency ablation) or extreme cold (cryoablation), PFA uses precisely controlled electrical pulses to selectively target and eliminate the cells responsible for abnormal heart rhythms.

This process, known as electroporation, enables targeted treatment of affected heart tissue while minimising impact on surrounding structures such as the oesophagus, phrenic nerve, and blood vessels. As a non-thermal technology, PFA represents a significant advancement in both safety and procedural efficiency.

With growing global clinical experience, PFA is increasingly being recognised as one of the most important recent advances in the management of cardiac arrhythmias.

The launch event was attended by Dr. N.S. Sivakadaksham, veteran cardiologist and Chief Guest, who welcomed the introduction of this transformative technology and highlighted its potential to improve outcomes for patients with heart rhythm disorders.

During the event, he also inaugurated Kauvery Hospitals’ new “Heart Rhythm Package”—a specially designed, affordable evaluation programme aimed at enabling early diagnosis and expert care for patients experiencing symptoms such as palpitations, breathlessness, dizziness, unexplained fatigue, or episodes of rapid heartbeat.

The package has been developed to promote early detection and timely treatment, which can significantly improve long-term outcomes and quality of life.

Speaking on the occasion, Dr. Deep Chandh Raja, Director of Cardiac Electrophysiology, Kauvery Hospitals, said, “Three patients were successfully treated at both centers with these procedures. One of the patients is a 69-year female with recurrent palpitations for 2 years. She tried different medicines for her irregular heart beats without any success. PFA procedure was performed within one hour through a key hole access in the right groin. She got discharged the very next day on minimum medicines. The safety, efficacy and fastness makes PFA a unique technology. We are proud to bring this next-generation treatment to Tamil Nadu.”

In addition to Pulsed Field Ablation, Kauvery Hospitals’ Department of Cardiac Electrophysiology offers comprehensive heart rhythm care, including advanced diagnostic services such as ECG, Holter monitoring, and electrophysiology studies, along with specialised arrhythmia clinics. The team also performs a wide range of complex ablation procedures and device therapies such as pacemakers, defibrillators, and cardiac resynchronisation therapy. Supported by state-of-the-art 3D mapping systems and a multidisciplinary team, the department delivers end-to-end care for even the most complex heart rhythm disorders. 

Dr. Aravindan Selvaraj, Co Founder and Executive Director, Kauvery Group of Hospitals, added, “At Kauvery Hospitals, we are committed to bringing proven, evidence-based innovations to our patients. Technologies that simplify procedures, enhance safety, and improve outcomes are central to our approach. The introduction of PFA reflects our continued commitment to delivering world-class cardiac care and ensuring access to the latest global advancements.”

With the simultaneous launch of both PulseSelect™ and Varipulse™ platforms, Kauvery Hospitals continues to strengthen its leadership in advanced cardiac care, offering patients across Tamil Nadu, neighbouring states, and international destinations access to some of the most innovative heart rhythm treatments available today.

A team of physicians led by Dr. Sweta Sahu is determined to change that — one daily activity at a time.
 

A doctor-led brain wellness initiative designed to support healthy ageing
 

Their initiative, ActiveMind Daily — part of the healthcare venture BlueprintRx — is now inviting 50 founding families to join a 10-day pilot of a doctor-designed brain wellness programme built specifically for older adults in Indian homes. Simple, screen-free, and grounded in science, the programme delivers one short daily activity targeting memory, language, attention, reflection, and family connection.
 

Filling a Need Families Don’t Know they have
India's elderly population is expanding at an unprecedented rate — yet conversations around brain health prevention remain largely absent from everyday elder care. Clinically, conditions such as diabetes, hypertension, and heart disease are routinely managed. Cognitive engagement, combating loneliness, and meaningful mental stimulation rarely receive the same attention — until decline becomes impossible to ignore.
 

Built for Real Indian Families
Unlike conventional wellness applications, ActiveMind Daily requires no login and no screen time from seniors. The programme is designed around the rhythms of Indian family life. Activities can be completed independently, with light family support, or through a brief phone call between a parent and an adult child living away from home.
 

Daily prompts draw on culturally familiar themes — childhood festival memories, beloved songs, regional proverbs, and food traditions — crafted to feel like conversation, not clinical exercises.
 

Reminders are delivered via WhatsApp or phone call, and progress is easy to track. Families who remain consistent through the first seven days receive a surprise gift. And if a day is missed, the programme accommodates catch-up sessions — because the goal, as the team emphasises, is rhythm, not perfection.
 

A Doctor-led Team with a Long-term Commitment

ActiveMind Daily is built by physicians who share a common belief: that brain health deserves the same everyday attention we give to the heart.
 

Dr. Sweta Sahu, Founder, is a physician and researcher with research and clinical experience at Johns Hopkins, the Cleveland Clinic, and the University of Alabama at Birmingham. She is a recipient of the American Heart Association’s 2025 Paul Dudley White International Scholar Award and has contributed to over 100 publications spanning cardiovascular medicine, gastroenterology, and population health.
 

"Brain wellness cannot wait for symptoms. Our goal is to make daily cognitive engagement as natural as a morning cup of chai — familiar, effortless, and something the whole family looks forward to.’”

Dr. Sri Sravya Thungathurthi, Physician and Co-founder of ActiveMind Daily, combines clinical training with a strong interest in healthy aging and preventive medicine. Through her exposure to healthcare systems in both India and the United States, she became increasingly interested in how early, proactive approaches to health can improve quality of life long before disease develops. Through ActiveMind Daily, she is helping raise awareness and build practical tools that promote cognitive wellness and meaningful family engagement for older adults in India.
 

“We designed these activities to meet families where they are—not in a clinic, but in their living rooms, around their dining tables, and in their everyday moments. Brain health is one of the most overlooked aspects of healthy ageing in India. In a world increasingly driven by short-form content, constant distractions, and passive consumption, we risk losing curiosity, creativity, and meaningful mental engagement. To me, ActiveMind Daily is a way to encourage a culture where keeping the mind active becomes a daily habit—not out of fear of decline, but as a celebration of lifelong learning, curiosity, and connection.”
 

ActiveMind Daily is supported by an expanding network of doctors, young medical interns, and students of Indian origin studying in U.S. high schools who work alongside its physician leadership team to contribute to research, programme development, participant feedback, and ongoing improvements. Together, they help ensure the initiative continues to evolve, adapt, and remain deeply relevant to the real-world needs of Indian seniors and their families.
 

The programme's activity framework is guided by evidence-based public health guidance on cognitive health and healthy ageing from the World Health Organization (WHO) and the National Institute on Ageing (NIA).
 

Join the founding pilot
The 10-day founding families pilot is now open and strictly limited to 50 families in the first batch. Families may begin with a free 30-second brain wellness check and sample three activities at no cost, or register directly through the ActiveMind Daily website.

Website: activeminddaily.in/check

Kauvery Hospital, Vadapalani, has successfully performed complex robotic colorectal cancer surgeries on three overweight and medically high-risk patients between 45-60 age group. Each patient weighed over 100 kilograms and had a BMI exceeding 38-40, along with associated medical conditions including diabetes, underlying cardiac issues, previous abdominal surgeries, and prior radiotherapy. Despite these added complexities, all three patients recovered rapidly and were discharged within four days of surgery.
 

Kauvery Hospital, Vadapalani
 

The patients were diagnosed with complex colorectal cancers, including very low rectal cancers and colon tumours located deep within the pelvis, an anatomically challenging region to operate on, particularly in overweight individuals and those with a history of prior abdominal surgeries or radiotherapy.

The surgeries were performed over three consecutive days by renowned robotic GI and colorectal surgeon Dr. Swaminathan Sambandham along with a multidisciplinary surgical and critical care team. The procedures were completed without large abdominal incisions. In an advanced minimally invasive approach aimed at reducing surgical trauma, the cancerous specimens were retrieved through the stoma site itself, thereby avoiding the need for additional abdominal cuts.

Despite the complexity and high-risk nature of the procedures, all three patients were mobilised early after surgery, experienced significantly less pain, and were discharged within just four days, an outcome considered highly notable in complex colorectal cancer surgeries involving obese and medically compromised patients.

Speaking about the procedures, Dr. Swaminathan Sambandham said, “These were among the most technically challenging colorectal cancer surgeries because of the patients’ obesity and associated medical conditions. Operating deep within the pelvis in overweight patients, especially those with previous surgeries or radiation history, is extremely demanding. Robotic surgery provides enhanced precision, better visualisation, and greater control, allowing us to perform these procedures safely while significantly reducing trauma to the patient.”

In his comments, Dr Aravindan Selvaraj, Co-founder and Executive Director, Kauvery Group of Hospitals, said, “Traditionally, such cases are considered surgically demanding due to restricted operating space, higher chances of blood loss, wound complications, infections, prolonged recovery, and increased post-operative risks. However, the surgical team at our hospital chose to manage all three cases using a completely robotic minimally invasive approach. The patients’ early mobilisation and discharge within four days despite the complexity of their condition reflects the advantages of advanced robotic surgery when combined with meticulous surgical planning and multidisciplinary care.”

The successful completion of these three consecutive complex robotic cancer surgeries further strengthens Kauvery Hospital Vadapalani’s growing expertise in robotic gastrointestinal and colorectal cancer surgery. The hospital continues to advance minimally invasive cancer care by combining cutting-edge robotic technology with highly specialised surgical expertise to deliver safer procedures, faster recovery, and improved patient outcomes even in the most challenging cases.

Dr. Devi Shetty - Narayana Health

The HIMSS AMAM framework is among the world’s leading benchmarks for assessing how healthcare organisations use data, analytics and AI to strengthen clinical outcomes and patient experience. Spread across seven stages, the model evaluates how deeply these capabilities are embedded into day-to-day decision-making. Stages 6 and 7 represent a highly advanced level of maturity, where predictive and near real-time intelligence are integrated into clinical and operational workflows at scale.

The recognition reflects Narayana Health’s sustained focus over the last decade on building a strong analytics foundation that supports decision-making across the organisation. What makes the milestone particularly noteworthy is that these capabilities have been developed and scaled within the cost-sensitive realities of the Indian healthcare ecosystem.

Reflecting on what shaped this journey, Dr. Devi Shetty, Founder and Chairman of Narayana Health, noted that the predominantly self-pay nature of Indian healthcare influenced the organisation’s analytics strategy from the very beginning. Without the cushion of insurance, gaps in bed utilisation, avoidable readmissions and prolonged hospital stays translate directly into out-of-pocket costs for patients and families. He said, “That reality pushed us to build operational and financial precision into every decision. We gave senior doctors visibility into metrics such as length of stay, procedure material costs, blood transfusions, re-exploration after surgery, mortality, morbidity and infection rates. Over time, this discipline has helped us steadily reduce mortality and morbidity, while improving productivity and keeping care within reach of our patients.”

Over the years, Narayana Health has evolved from conventional reporting structures into an integrated enterprise-wide analytics ecosystem supporting hundreds of use cases across clinical care, hospital operations and resource planning. The organisation has consistently invested in innovation and digital capability development to remain ahead of the curve as healthcare systems globally move towards data-driven models of care.

Commenting on the milestone, Dr. Emmanuel Rupert, Managing Director and Group CEO, Narayana Health, said, “Healthcare systems globally are being reshaped by the ability to use data meaningfully and responsibly. At Narayana Health, we recognised early on that analytics would be central to delivering better outcomes for patients at scale, while remaining grounded in the realities of Indian healthcare delivery. Achieving this level of validation reflects years of focused effort across teams, and reinforces our belief that world-class innovation can be built within India, for India.”

Today, analytics capabilities, powered by Medha AI, support a wide range of functions across the network, from improving patient flow and reducing waiting times to optimising workforce and bed utilisation. The organisation has also developed and deployed several in-house technology solutions designed around high-volume clinical workflows. One such example is Medha Scribe, an ambient documentation platform implemented in echocardiography workflows at Narayana Institute of Cardiac Sciences. By capturing findings during procedures and automatically populating reporting fields, the solution has significantly reduced report turnaround times while enabling clinicians to continue working within familiar workflows. Similar capabilities are now being extended across radiology, outpatient consultations and operation theatre documentation. In parallel, structured clinical data systems have supported the development of India-specific research and predictive models, including the NH Pre-Operative Risk Score for CABG surgeries and AI-assisted ECG models aimed at enabling earlier detection of cardiac abnormalities, particularly in resource-constrained settings.

Mr. Vivek Rajagopal, Group Chief Analytics & AI Officer, added, “Our focus has been to make analytics practical, accessible and deeply embedded into everyday healthcare delivery rather than treating it as a standalone technology layer. We have built a unified ecosystem where clinical, operational and financial insights come together to help teams make faster and more consistent decisions. The HIMSS Stage 6 validation reflects not just technology maturity, but also the culture, governance and cross-functional collaboration required to operationalise analytics meaningfully at scale.”

Beyond the validation itself, the HIMSS AMAM assessment process also helped strengthen governance frameworks around analytics implementation, monitoring and accountability across the organisation. The external review examined both technical capability and measurable real-world impact across areas such as patient safety, quality of care and resource management. With this recognition, Narayana Health joins a select group of healthcare organisations globally to achieve this level of analytics maturity, marking another step forward in its continuing effort to build scalable, technology-enabled and patient-centric healthcare systems.

About Narayana Health
Narayana Health, founded by Dr. Devi Shetty and headquartered in Bengaluru, is a leading presence in the global healthcare landscape. As one of the largest healthcare providers in India, Narayana Health operates a comprehensive range of primary, secondary and super-speciality tertiary care facilities across India and the Caribbean. The group’s Centres of Excellence in various medical domains, a team of 18,822 dedicated professionals, including 3,868 skilled doctors and specialists, and a relentless focus on patient well-being and clinical excellence underscore its position as a beacon of hope and healing in the healthcare industry. Narayana One Health (NH Integrated Care) and Narayana Health Insurance are subsidiaries of Narayana Health.

For more information, visit https://www.narayanahealth.org.

Basic Life Support and Automated External Defibrillator (AED) awareness and training program

AED is a life-saving device used during sudden cardiac arrest. It can quickly assess the heart’s rhythm and deliver a controlled electrical shock when required, helping restore normal heart function and significantly improving survival chances. As part of its ongoing commitment to community health and public safety, Kauvery Hospital had earlier donated four AED devices to Salem Railway Station to improve emergency medical response infrastructure at the station. 

The training program was attended by Dr. Sivakumar, Chief Medical Officer, Southern Railway, along with the Railway Station Master and Railway Station Manager. The training was designed to ensure that railway staff are equipped with the knowledge and practical skills required to respond effectively during sudden cardiac arrests and other medical emergencies until advanced medical care becomes available.

The session was led by senior emergency medicine specialists from Kauvery Hospital, who provided hands-on training on BLS techniques, cardiopulmonary resuscitation (CPR), and the proper use of an AED. Through live demonstrations and interactive learning sessions, participants gained valuable insights into recognising medical emergencies and delivering timely first-response care that can significantly improve survival outcomes.

Speaking on the occasion, Dr. Mubeena Anjum, Consultant - Emergency Medicine, Kauvery Hospital, Salem, highlighted the critical importance of immediate intervention during cardiac emergencies. She emphasised that timely CPR and early defibrillation can substantially increase the chances of survival and that empowering frontline personnel in high-footfall public locations such as railway stations can save precious lives.

L-R: Dr. Karthik Ramasamy and Chief Guest Prof. Dr. Venkat Ramakrishnan, Senior Consultant Plastic & Reconstructive Surgeon, Apollo Hospitals Chennai & Chennai Breast Center

The comprehensive workshop led by Dr. Karthik Ramasamy, Chennai’s renowned Plastic and Cosmetic Surgeon, provided participants with advanced training in the evaluation and management of gynecomastia across all grades. The academic sessions covered key aspects including patient assessment, gynecomastia grading, surgical planning, liposuction-assisted chest sculpting, gland excision, puffy nipple correction, skin tightening procedures, scar minimization, and advanced male chest contouring techniques.

The distinguished faculty panel, comprising Dr. Venkatramakrishnan, Dr. Sivakumar, Dr. Sasi Kumar Muthu, Dr. TNS, Dr. M.D. Nishar, Dr. Preethy, and members of the Chennai Plastic Surgery team, shared their extensive clinical expertise, refined surgical techniques, and practical insights. The faculty emphasized the importance of achieving a natural masculine chest aesthetic while maintaining the highest standards of patient safety, surgical precision, and optimal clinical outcomes in gynecomastia surgery and male chest contouring procedures.

Speaking at the workshop, Dr. Karthik Ramasamy said, “The future of plastic surgery depends on structured training, technology adoption, and hands-on clinical exposure. At Chennai Plastic Surgery, our focus is on advancing gynecomastia surgery, chest sculpting, male chest contouring, and body contouring through live surgical demonstrations and evidence-based learning. Such academic initiatives strengthen surgical decision-making, enhance precision, and improve outcomes in aesthetic surgery practice.”

Beyond Surgery: Integrating Technology, Practice Growth and Next-Generation Plastic Surgery Training

Live Surgical Demonstrations and Clinical Learning

A major highlight of the workshop was the live surgical demonstration of gynecomastia correction procedures performed on patients with varying grades of the condition. Participants observed real-time operative planning, surgical decision-making, advanced chest sculpting techniques, and management of complex cases, along with interactive case discussions and question-and-answer sessions that enriched the overall learning experience in gynecomastia surgery and male chest contouring.

Technology Integration in Modern Aesthetic Surgery

Significant technological value was added through the participation of Mr. Ramamoorthy Sundaram, Managing Director of Spectra, and Mr. Prabakaran, Technical Director of Spectra, who demonstrated advanced energy-based technology devices used in modern aesthetic and surgical procedures.

Participants gained insights into clinical applications, safety protocols, and innovations in energy-based devices, highlighting their role in enhancing surgical precision, improving patient outcomes, and optimizing aesthetic treatment results in body contouring and aesthetic medicine.

Plastic Surgery Practice Building and Growth Strategies

The workshop featured dedicated sessions on plastic surgery practice building, covering key areas such as patient communication, ethical marketing, digital branding, online presence, practice management, reputation building, and consistent patient outcomes.

These sessions provided valuable guidance for young surgeons and aesthetic practitioners seeking to establish and expand successful practices in plastic surgery and aesthetic medicine.

Future of Plastic Surgery Training in India

Discussions on the future of plastic surgery training in India highlighted the growing importance of structured fellowships, cadaveric workshops, simulation-based learning, international collaborations, and exposure to high surgical volumes.

Experts noted that modern plastic surgery education in India is increasingly aligning with global standards, offering training experiences comparable to leading international programs.

About Chennai Plastic Surgery

Chennai Plastic Surgery is a leading centre specializing in plastic surgery, cosmetic surgery, gynecomastia surgery, body contouring, facial aesthetics, reconstructive surgery, and advanced aesthetic procedures. The institution is committed to delivering exceptional patient care while actively promoting surgical education, innovation, and professional development through specialized workshops, fellowships, and academic training programs.

To watch the program surf: youtu.be/ZRyCNEVYeXg.

Kauvery Hospital, Radial Road

 
The patient, a young professional, initially developed a severe headache that persisted despite regular medication. When he subsequently developed vomiting and increasing drowsiness, his friends rushed him to Kauvery Hospital.
 
The emergency medicine specialists immediately recognised the seriousness of his condition and rapidly alerted the neurocritical care and neurosurgery teams. A CT scan performed within minutes revealed a giant brain tumour on the right side of his brain that had bled extensively, causing dangerous pressure on vital brain structures.
 
Even as the scan was being completed, the patient’s condition deteriorated rapidly, and he had to be intubated to support his breathing. The neurosurgery team, led by Dr J. Emmanuel Thas, Senior Consultant, Neurosurgery, rushed the patient to the operating theatre and undertook a marathon emergency surgery through the night to decompress the brain and remove the giant tumour.
 
The patient regained consciousness within 36 hours of surgery. He was discharged from the hospital in a week and is all set to resume work soon.
 
Commenting on the case, Dr Emmanuel Thas said, “The patient was brought to the hospital in a critical condition with severe headache, vomiting, and rapidly worsening drowsiness. Considering the life-threatening nature of the situation, we proceeded with emergency surgery through the night to relieve the pressure on the brain and remove the tumour. Early recognition, rapid intervention, and close coordination between the emergency, neurocritical care, anaesthesia, and neurosurgical teams played a crucial role in achieving a good recovery for the patient.”
 
In his comments, Dr Krish Sridhar, Group Mentor, Neurosciences & Director, Institute of Brain & Spine, said, “This outcome demonstrates what is possible in modern-day neurosurgery when multiple teams come together seamlessly and work in a fast, coordinated, and highly synchronised manner to achieve the best outcomes in a critically ill patient." The doctors and staff of the Emergency Medicine, Neuro Critical Care and Neurosurgery departments are to be congratulated on this heroic effort that has shown that even what seems an impossible task can be successful if the response is rapid and integrated. The story gains special significance as we approach World Brain Tumour Day on June 8, a day dedicated to raising awareness about brain tumours and reminding patients and families that effective treatment and excellent outcomes are possible.”
 
In his comments, Dr Aravindan Selvaraj, Co - Founder & Executive Director, Kauvery Group of Hospitals, said, “The successful intervention gains special significance as we approach World Brain Tumour Day on June 8, a day dedicated to raising awareness about brain tumours and reminding patients and families that effective treatment and excellent outcomes are possible. With timely diagnosis, advanced imaging, specialised neurocritical care, and modern neurosurgical techniques, even life-threatening brain tumours can often be treated successfully. We remain committed to providing comprehensive, multidisciplinary neurosciences care that gives patients the best possible chance of recovery and return to normal life.”
 

Celebrating a landmark in cardiac care, the team at Narayana Health City successfully performed India’s first Pulsed Field Ablation (PFA) for Atrial Fibrillation

As the first centre in India to perform Pulsed Field Ablation (PFA), Narayana Health has integrated this platform with its unique Comprehensive AFib management programme with an intention to deliver state-of-the-art, minimally invasive, and safe AFib ablation to patients suffering from the disease. The Institute performs this procedure on globally recognised technology systems such as Johnson & Johnson, Abbott, Boston Scientific, and Medtronic.

This allows physicians to perform procedures with enhanced precision and efficiency. The technology is safe, patient-centric and compatible with both conscious and deep sedation thereby paving the path towards shorter hospital stays and recovery periods. Narayana Health, with its focus on greater accessibility, offers mechanisms for patients of various socio-economic backgrounds to avail this procedure at prices as low as Rupees 2.5 lakhs despite the use of imported technologies.

Commenting on this significant landmark, Dr. Devi Prasad Shetty, Founder and Chairman, Narayana Health, said, “Pulsed Field Ablation represents a defining leap in the future of cardiac rhythm management. It uses ultra-fast electrical pulses to selectively target cardiac tissue, while preserving surrounding critical structures and minimising damage. This makes it one of the safest and most promising breakthroughs in Electrophysiology in recent times and ushers in a new era in rhythm management in our country. Atrial Fibrillation affects nearly 50 million people worldwide with the prevalence increasing as the age of the population increases. It contributes to 20 per cent of brain strokes with an unknown cause, and incites and worsens heart failure. It is also known to contribute to dementia by causing minor brain infarcts and reducing blood flow to the brain.

In Atrial Fibrillation, the heart’s upper chambers beat out of sync with the lower chambers, making them quiver or ‘fibrillate’ rapidly. This disrupts the heart’s coordinated pumping, causing the blood to collect inside the heart instead of being pumped out fully. This is the mechanism of the clot formation as well as heart failure. In addition, owing to the higher heart rate and poor filling of the cardiac chambers, exercise reserve is reduced leading to a vicious cycle of heart failure, Atrial Fibrillation and Atrial muscle weakness.”

A person experiencing AFib may feel a fluttering sensation in their chest, unusual fatigue, dizziness, or even shortness of breath. While these symptoms can be managed with medications and blood thinners, the best remedy in the long term would be to restore a normal cardiac rhythm.

Hitherto, patients underwent traditional thermal ablation, a minimally invasive catheter-based technique which uses targeted heat or cold to destroy tissue responsible for abnormal electrical signals in the heart, but with a high likelihood of damage to surrounding structures.

Early clinical studies on Pulsed Field Ablation have demonstrated considerable safety, effectiveness, faster recovery times, and shorter duration of the procedure, which means that patients spend less time on the operating table.

Dr. Devi Shetty further added, “As India embraces next-generation cardiac care, the adoption of PFA needs to be supported by rigorous clinical evaluation, structured training for physicians, and strong institutional protocols to ensure effective integration into mainstream practice. This technology has the potential to dramatically reduce procedure times, improve recovery, and redefine the standards of care for patients with complex cardiac arrhythmias. We believe that successful Atrial Fibrillation management extends beyond the procedure itself and requires a comprehensive, patient-centric approach.”

Elaborating about PFA, Dr. Deepak Padmanabhan said, “Patients increasingly seek therapies that are effective, minimally invasive, and associated with quicker recovery. The procedure is performed using a fine catheter, guided through the blood vessels in the leg. Most patients will require just an overnight stay in the hospital and can return to work quickly. It also enables hospitals to be able to deliver care effectively and scale the therapy to cater to the growing needs of our burgeoning population.”

Dr. Kapil Kumawat said, “The most important step remains early recognition. Persistent palpitations, irregular heartbeat, unexplained fatigue, dizziness, or breathlessness should not be ignored. Early diagnosis and timely evaluation can reduce the risk of complications, including brain stroke and heart failure. Even after a successful ablation, patients will need structured, long-term follow-up to maintain heart health. This includes managing overall cardiovascular risk factors—through brain stroke prevention, controlling BP, diabetes and weight management, being consistent with exercise routines and treatment of sleep apnoea.”

Dr. Debabrata Bera said, “As Electrophysiologists, our goal is to provide patients with durable rhythm control while reducing procedural risks and recovery times. Pulsed Field Ablation brings us significantly closer to achieving that objective and offers renewed hope for patients living with Atrial Fibrillation. It also democratises the procedure delivery since the learning curve is expected to be less steep than the existing ablation technologies.”

Narayana Health has developed and deployed advanced technologies to treat electrical disturbances of the heart, generally referred to as Arrhythmias. Comprehensive AFib services are available throughout its network of hospitals across the country.

About Narayana Health

Narayana Health, founded by Dr. Devi Shetty and headquartered in Bengaluru, is a leading presence in the global healthcare landscape. As one of the largest healthcare providers in India, Narayana Health operates a comprehensive range of primary, secondary, and super-speciality tertiary care facilities across India and the Caribbean.

The group's Centres of Excellence across multiple medical specialties, a team of 18,822 dedicated professionals including 3,868 skilled doctors and specialists, and a relentless focus on patient well-being and clinical excellence underscore its position as a beacon of hope and healing in the healthcare industry.

Narayana One Health (NH Integrated Care) and Narayana Health Insurance are subsidiaries of Narayana Health.

For more information, visit www.narayanahealth.org.

Metropolis leadership team – Dr. Kirti Chadha, Dr. Vani Ravikumar, Dr. Ravikumar HN and Dr. Naveen Kumar S at the event

The recognition acknowledges Metropolis’ leadership in building a robust, technology-enabled quality ecosystem that delivers accurate, reliable, and clinically meaningful diagnostics to millions of patients across India. At the core of this achievement is Metropolis’ integrated quality intelligence framework, which combines scientific rigour, data-driven governance, advanced analytics, standardised laboratory practices, and continuous quality monitoring to ensure consistency across the entire diagnostic journey—from sample collection and transportation to testing and report delivery.

Achievements at a Glance

Metropolis today delivers 99.99% report accuracy across 3,512 diagnostic tests, maintains 100% compliance with ISO 15189:2022 standards across accredited laboratories, and stringently monitors quality data points through advanced analytics platforms. Its quality ecosystem is further strengthened by 582 NABL-accredited sample collection facilities, and a network of more than 275 authorized signatories providing scientific oversight and governance over reporting and verification of all new test/ method/ platform before induction.

Metropolis has consistently invested in building one of India's most comprehensive laboratory excellence ecosystems. Its network-wide governance framework spans over 210 laboratories and thousands of patient touchpoints, supported by NABL and CAP accreditations, standardised SOPs, structured audit systems, real-time monitoring, and analytics-driven quality control processes.

A key differentiator has been the introduction of the Quality Score Index (QSI), a first-of-its-kind scientific performance framework that establishes measurable and uniform benchmarks across laboratories. The framework evaluates performance across multiple scientific and operational parameters, including audit outcomes, external quality assurance performance, compliance indicators, complaint resolution timelines, and academic engagement metrics, helping drive continuous improvement across the network.

Building on this foundation of measurable quality, Metropolis has developed advanced scientific and digital initiatives, including an AI-assisted Directory of Services and Tests and ‘Next Best Action’ clinical intelligence tools that support evidence-based diagnostic interpretation and clinical decision-making. The framework is further supported by annual audits aligned with ISO 15189, CLSI, and CAP guidelines, along with Internal Quality Control (IQC) analytics, digital audit management systems, and real-time intelligence dashboards. Together, these enable proactive identification of quality gaps, faster corrective actions, and continuous improvement across the network. Collectively, these initiatives translate into greater diagnostic confidence, improved consistency, and more informed clinical decision-making for patients and healthcare providers.

Commenting on the recognition, Mr. Surendran Chemmenkotil, Managing Director, Metropolis Healthcare Limited, said, "Quality in diagnostics directly impacts clinical decision-making and patient outcomes, making it one of the most critical responsibilities in healthcare. This recognition validates our long-standing commitment to building a deeply integrated and standardised ecosystem across our network. As we continue to expand our footprint, our focus remains on ensuring that every patient, irrespective of location, receives the same high standard of diagnostic accuracy, reliability, and scientific excellence. Initiatives such as the Quality Score Index and Pre-Analytical Compliance (PAC) framework reflect our commitment to making excellence measurable, transparent, and continuously improvable."

Dr. Kirti Chadha, Chief Scientific and Innovation Officer, Metropolis Healthcare Limited, added: "At Metropolis, quality is not viewed as a checkpoint, but as a continuously evolving scientific discipline embedded into every stage of laboratory operations. Our integrated quality intelligence framework combines rigorous accreditation standards, structured governance, advanced analytics, internal quality controls, EQAS (External Quality Assurance Scheme) monitoring, and continuous skilling of laboratory professionals. This recognition reflects the collective commitment of our scientific and operational teams towards delivering consistent, reliable, and clinically meaningful diagnostics."

Supported by 100% participation in External Quality Assurance Programmes (EQAS/PT), specialist-led medical governance, and over four decades of diagnostic expertise, Metropolis remains committed to advancing diagnostic excellence, strengthening patient trust, and improving healthcare outcomes through scientific innovation and operational discipline.

*NABL - National Accreditation Board for Testing and Calibration Laboratories

*CAP - College of American Pathologists

*CLSI - Clinical and Laboratory Standards Institute

About Metropolis Healthcare Limited

Established in 1981, Metropolis Healthcare Limited is India’s second-largest diagnostic chain, led by visionary leader Ms. Ameera Shah. With over four decades of excellence, Metropolis has been a pioneer in delivering best-in-class diagnostic services to patients, healthcare providers, and corporates across India and Africa. The company’s extensive footprint spans 28 states, 7 Union Territories, and over 750+ towns in India, supported by a robust network of more than 219 laboratories, 5000 plus patient service centers, and over 10,000 touchpoints. Each year, Metropolis serves millions of individuals by providing actionable health insights that empower better clinical outcomes. Metropolis offers a comprehensive range of more than 4,100 tests and profiles, including advanced tests for diagnosing cancer, neurological disorders, infectious diseases, and various genetic abnormalities. The company’s commitment to quality and accuracy is reinforced by its consistent CAP proficiency score of over 99% for the past decade, placing it among the top 1% of laboratories worldwide for quality assurance. The Metropolis philosophy is built on the pillars of technological superiority, a warm, patient-centric approach, and reliable diagnostic reports.

sFor more information, please visit www.metropolisindia.com or click on Twitter, Facebook, or LinkedIn

Three Lives, One Second Chance: Advanced Heart Pumps Bridge Three Teenagers to Successful Heart Transplants at Narayana Health

All three teenagers, who arrived separately at the hospital in extremely critical condition, have now returned home to their families following successful heart transplants.

Bridging the Gap to Survival

When the teen patients were admitted, their hearts were too weak to sustain life. To buy them precious time, doctors implanted mechanical pumps that took over the work of their failing hearts. These devices acted as a bridging support, stabilising their hearts and keeping the young patients alive while they were placed at the top of a priority list for transplantation.

In a region where donor organs are often scarce and waiting lists can be long, suitable matches were remarkably found for all three patients within 28 to 45 days.

Three Inspiring Stories of Recovery

The three cases highlight the complexity and success of the hospital’s paediatric heart programme:

• Case 1: A teenager suffering from severe heart dysfunction and dangerous blood clots was supported by a machine that assisted both sides of his heart (a BiVAD). After 45 days on the device, he received a transplant and was discharged from hospital in just a few weeks.

• Case 2: Diagnosed with a condition where the heart becomes stretched and weak, this teenager was kept alive by a mechanical pump for 28 days before a successful transplant was performed.

• Case 3: A childhood cancer survivor who had previously lost a kidney to a tumour, faced a new battle with heart failure. Supported by an artificial pump for 30 days, he successfully underwent a transplant, marking a triumphant recovery against all odds.

A New Era for Specialist Care in India

This medical milestone for the hospital represents a significant shift in the availability of advanced medical treatment in India. Previously, these complex therapies were only accessible at a handful of specialised centres worldwide.

“These young patients were at the very edge of survival. Using artificial pumps to keep them alive until a donor heart became available, was a landmark moment for heart failure care in the country,” said Dr. Shashiraj Subramanya H S, Head of Paediatric Cardiology, Narayana Health.

“Over the last decade, we have worked to make these advanced technologies a reality for families who previously had no options. Today, these life-saving treatments are achievable in India through better systems and a focus on making healthcare affordable,” said Dr. Varun Shetty, Senior Consultant – Cardiac Surgery, Narayana Health.

“When these patients first arrived, survival looked nearly impossible. VADs acted as lifesaving bridges, keeping them alive until donor hearts arrived. Seeing them return home smiling with their families is one of the proudest moments for our entire team.” said Dr. Riyan Sukumar Shetty, Director of Paediatric Intensive Care, Narayana Health

About Narayana Health

Narayana Health, founded by Dr. Devi Shetty and headquartered in Bengaluru, is a leading presence in the global healthcare landscape. As one of the largest healthcare providers in India, Narayana Health operates a comprehensive range of primary, secondary and super-speciality tertiary care facilities across India and the Caribbean. The group’s Centres of Excellence in various medical domains, a team of 18,822 dedicated professionals, including 3,868 skilled doctors and specialists, and a relentless focus on patient well-being and clinical excellence underscore its position as a beacon of hope and healing in the healthcare industry.

Narayana One Health (NH Integrated Care) and Narayana Health Insurance are subsidiaries of Narayana Health.

For more information, visit www.narayanaone.health.

The Antara Integrated Wellness Clinic in DLF Phase 2, Gurugram

Globally, integrative medicine has gained acceptance for its role in improving outcomes in chronic disease management and enhancing quality of life. The World Health Organisation (WHO) recognises it as an interdisciplinary, evidence-based approach that combines conventional medicine with traditional therapies, such as Ayurveda and energy healing, to look at the mind, body and spirit together; the focus is on the root cause of illness, not just its symptoms.

Ms. Tara Singh Vachani, Executive Chairperson, Antara Senior Care, said, “Antara has spent more than a decade walking alongside families through all stages of ageing. We have seen them navigate the complexities of a fragmented healthcare system, disjointed treatment plans and episodic care that seldom restore quality of life. Antara Integrated Wellness Clinic is our answer to preserve seniors’ dignity and independence. It is built on the conviction that patients’ problems should be addressed holistically as good health is a combination of physical, emotional, mental, and social wellbeing. As India’s senior population and chronic disease burden grow, fully integrated, holistic wellness models will become key to unlocking a healthy society.”

Mr. Rajit Mehta, CEO & MD, Antara Senior Care, said, “Indians are living longer, but the years added are too often years lived with disease, dependency and fatigue. The gap between lifespan and health span is the gap we strive to close. Our goal is straightforward: help seniors live their best life possible; prevent the hospital visits we can, reduce medication where possible, and restore function where we can. At AIWC, seniors benefit from a coordinated care journey designed by one multidisciplinary team, beginning with a comprehensive health assessment, followed by personalised wellness plan, and multi-pronged approach that addresses physical, mental and emotional health.”

Dr. Pankaj Verma, Medical Director, Antara Integrated Wellness Clinic, explained, “In integrative medicine, modern medicine is the anchor, and traditional systems work alongside it to address lifestyle, stress, the inflammation that sits underneath chronic diseases. For a senior with diabetes, hypertension and joint pain, coming to AIWC means a clear focus on addressing the root cause—the hidden mind-body link that often feeds the disease. Over time, many of our patients can reduce their pill load and recover function they had given up on. This is what whole-person medicine looks like in practice.”

Antara’s integrative clinic offerings combine functional medicine consultations, Ayurvedaprakriti analysis, advanced therapies such as IV cellular nutrition (high-dose Vitamin C, Glutathione), medical-grade ozone therapy and Far Infrared sauna, classical Ayurveda and Panchakarma, acupuncture, energy and vibrational healing, and integrative counselling. Care is organised through 10 condition-focused programmes: JointCare, HeartCare, DiabetesCare, BreathCare, GutCare, LiverCare, MindCare, WeightCare, and CancerCare, the last designed as complementary support alongside standard oncology care.

For India, care pathways like integrative medicine are becoming increasingly important as its senior population is set to more than double to 347 million by 2050, bringing with it unique clinical needs that the traditional healthcare system cannot address alone.

About Antara Senior Care

Launched in 2013, Antara is the senior-care business of Max India Limited, part of the USD 7-billion Max Group. It is an integrated ecosystem for senior care, operating in two main lines of business – Residences for Seniors and Assisted Care Services. Antara’s first senior residential community in Dehradun, comprising nearly 200 families, caters to their social, recreational, educational, wellness, and health-related needs. In the near future, it will open its second senior living community in Noida’s Sector-150, with families moving into the 340 apartments built in the first phase. Expanding its footprint in Gurugram, Antara will manage senior living residences, dedicated spaces for senior living, and primary healthcare services at Estate 360 and Estate 361, developed by Max Estates. Antara’s Assisted Care Services include Care Homes and Services, AGEasy, and Antara Integrated Wellness Clinic. This line of business caters to seniors, who need more immersive interventions in their daily lives due to medical or age-related issues. With eight facilities and 485 beds across Gurugram, Noida, Bengaluru and Chennai, Care Homes provide long-term care to seniors who require constant medical and nursing supervision, and short-term care services for the recuperation of seniors. Its care at home services, offered in Delhi NCR, Bengaluru and Chennai, provide well-equipped, trained professionals offering care to seniors inside their home’s comfort. AGEasy, an online and offline store focusing on senior-specific products and solutions to manage chronic health conditions at home, has touched over 6.5 lakh lives since inception in 2023. Antara Integrated Wellness Clinic combines modern medicine with evidence-based traditional therapies through a multidisciplinary team of doctors to deliver personalised care plans.

Dr. Naveen Padmanabhan, Consultant & Head of Surgical Oncology at Equitas Hospital, Chennai, Expert in GI, breast, and thoracic oncology
 

The Importance of Awareness and Early Detection

One of the most effective ways to combat cancer is through awareness and timely medical intervention. Many cancers develop gradually and may not show obvious symptoms in their early stages. Regular health check-ups, understanding family medical history, and paying attention to unusual changes in the body can play a crucial role in early diagnosis.
 

Common warning signs that women should not ignore include:

• Unexplained lumps or swelling

• Persistent abdominal bloating

• Abnormal bleeding or discharge

• Sudden weight loss

• Chronic fatigue

• Changes in bowel or bladder habits

• Persistent pain that does not resolve
   

Seeking medical attention at the earliest sign of concern can significantly improve treatment success rates.
 

How Cancer Treatment Has Evolved

Cancer treatment has witnessed remarkable advancements over the past decade. Today, treatment plans are personalized based on the type of cancer, stage of disease, and overall health of the patient. Multidisciplinary teams comprising surgeons, oncologists, radiologists, and pathologists work together to deliver comprehensive care.
 

Among the most significant developments has been the evolution of surgical techniques that focus on effective cancer removal while preserving healthy tissue and improving recovery outcomes.
 

Advanced Surgical Options for Women’s Cancers

Modern cancer surgery has moved beyond traditional open procedures in many cases. Advanced techniques now offer greater precision, reduced pain, and faster recovery.
 

Minimally Invasive Surgery Many gynecological and abdominal cancers can now be treated using minimally invasive techniques. These procedures require smaller incisions, resulting in less blood loss, reduced postoperative discomfort, shorter hospital stays, and quicker return to daily activities.
 

Laparoscopic Surgery Laparoscopic procedures utilize specialized instruments and high-definition cameras to remove tumors with exceptional precision. This approach has become increasingly common in the treatment of certain uterine, ovarian, and cervical cancers.
 

Robotic-Assisted Surgery Robotic technology has further enhanced surgical precision by providing surgeons with improved visualization and greater control during complex procedures. This enables more accurate tumor removal while preserving surrounding healthy structures whenever possible.
 

Organ-Preserving Surgeries Advances in surgical planning and imaging allow doctors to remove cancerous tissue while preserving organ function whenever clinically appropriate. Such approaches can significantly improve long-term quality of life for patients.
 

Dr. Naveen Padmanabhan, Consultant & Head - Surgical Oncology at Sringeri Sharada Equitas Hospital says that, “Cancer is no longer viewed solely as a life-threatening diagnosis. With increasing awareness, timely diagnosis, advanced surgical techniques, targeted therapies, and comprehensive cancer care, many women are successfully overcoming cancer and leading healthy, fulfilling lives.”
 

He also emphasized that awareness, regular medical consultations, and prompt attention to symptoms remain the strongest tools in the fight against cancer. By prioritizing their health and seeking timely medical advice, women can greatly improve their chances of successful treatment and long-term well-being.
 

Remember: Early action can make all the difference. Awareness today can save lives tomorrow.

Doctors at Prayag Hospital successfully performed a complex high-risk trauma surgery on a 74-year-old road accident patient

Mr. Ram Sharan Lal, a known case of heart disease, diabetes mellitus, and hypothyroidism, was admitted under the Ayushman panel at the hospital on January 5, 2026, in an extremely critical condition. He presented with severe abdominal pain and distension, repeated vomiting, fever, and shock, all signs suggestive of a serious abdominal emergency associated with systemic infection.

The patient was immediately shifted to the Intensive Care Unit (ICU), where a multidisciplinary team initiated aggressive resuscitation and stabilization. Considering his advanced age and multiple co-morbidities, the case was categorized as extremely high-risk. His cardiac condition and diabetes were carefully stabilized, and blood transfusion was administered to improve his condition prior to surgery.

On January 6, 2026, the patient underwent emergency life-saving surgery performed by Dr. V. S. Solanki. During the procedure, doctors identified gangrenous small intestine that had lost blood supply and become non-viable. The affected segment was successfully removed, following which healthy bowel segments were reconnected. Large amounts of pus and infected fluid were drained from the abdominal cavity, and the associated hernial defect was also repaired.

Despite multiple medical challenges, the patient responded positively to treatment and remained under close post-operative monitoring in the ICU and ward. He showed steady clinical recovery and was discharged in stable and satisfactory condition on January 9, 2026.

Mr. Ram Sharan Lal and his son, Mr. Rajan Srivastava, expressed gratitude towards the doctors, nursing staff, and hospital management for the timely intervention, expert surgical care, and dedicated patient management that helped save his life.

Dr. V. S. Solanki, Senior Surgeon at Prayag Hospital and Research Centre Pvt. Ltd., said, “This was an extremely challenging case because the patient arrived in shock with multiple co-morbidities and severe abdominal infection. Timely surgical intervention, critical care support, and coordinated teamwork played a crucial role in achieving a successful outcome. At Prayag Hospital, our focus remains on delivering prompt and comprehensive care even in the most high-risk emergencies.”

Pritika Singh, Chief Executive Officer (CEO), Prayag Hospitals, said, “Managing such a critically ill elderly patient with multiple co-morbidities required exceptional coordination, rapid decision-making, and advanced clinical expertise. This successful outcome reflects the dedication of our doctors, ICU specialists, nursing teams, and support staff who work tirelessly to provide timely and compassionate care to every patient. At Prayag Hospitals, patient safety and quality healthcare remain our highest priorities.”

Doctors noted that the case was especially challenging due to the patient’s advanced age, pre-existing heart disease, diabetes mellitus, hypothyroidism, shock at the time of admission, and severe abdominal infection caused by gangrenous intestine with peritonitis. The need for emergency bowel resection, blood transfusion, intensive care support, and post-operative monitoring further highlighted the complexity and high-risk nature of the case.

The successful management of this case highlights the importance of timely diagnosis, advanced ICU support, experienced surgical expertise, and coordinated multidisciplinary care available at Prayag Hospital and Research Centre Pvt. Ltd..

About Prayag Hospital

Prayag Hospital and Research Centre Pvt. Ltd. began its journey in 1995 as Prayag Orthopedic Centre, a dedicated clinic in Sector 29, Noida, founded by Dr. B. P. Singh. Established on the principle of “Sewa Parmo Dharma,” meaning service is the highest duty, the institution has grown with a commitment to compassionate, ethical, and patient-centric healthcare.

Today, Prayag Hospital is a 120-bedded NABH and NABL accredited hospital equipped with advanced medical infrastructure and supported by experienced doctors, nurses, and healthcare professionals. The hospital provides comprehensive services across general medicine, surgery, orthopaedics, emergency care, maternal and child health, and specialized treatments.

Over the years, the hospital has earned the trust of patients through quality healthcare, ethical practices, accessible treatment, and dedicated patient support services. It is also empanelled under various government healthcare schemes and recognized by multiple TPA panels to ensure affordable and accessible healthcare for eligible families.

Dr. Kashinath Samagandi, Director, Morarji Desai National Institute of Yoga at the signing ceremony between MDNIY and Habuild

As part of the yoga 365 initiative, Habuild and MDNIY, Ministry of Ayush rolled out a large-scale digital yoga movement (in March 2026) leading up to June 21, 2026, with the objective of encouraging people to practise yoga consistently every day for 100 days. The initiative has already seen participation from over 4 lakh active participants from 130+ countries and every Indian state and Union Territory and is expected to grow multifolds until June 21. 

The initiative introduces participants to simple yoga practices that can be integrated into everyday life via the Youtube channel of the Ministry of Ayush. The guided sessions are led by Saurabh Bothra, Co-Founder  and Yoga Instructor of Habuild, whose approach to yoga focuses on habit formation, mindful movement, and building sustainable wellness routines rather than short-term fitness goals. The format has been designed to ensure that everyone can comfortably participate and gradually build a consistent yoga practice.

The initiative reflects a shared vision between MDNIY, Ministry of Ayush and Habuild to expand the reach of yoga through digital platforms while strengthening the culture of preventive healthcare in India. 

Commenting on the initiative, Saurabh Bothra, Co-founder, Habuild, said, “Yoga becomes transformative when it moves from an occasional activity to a quiet daily discipline. India has always had a deep cultural relationship with yoga, yet modern lifestyles often make it difficult for people to stay consistent. Through this collaboration with MDNIY, Ministry of Ayush, we hope to create a simple pathway for people to begin and sustain that relationship again. When millions of people practise even a few minutes of yoga every day, the impact extends far beyond individual wellbeing and begins to shape a healthier society.”

Over the years, global observance of International Yoga Day on June 21 has helped introduce yoga to millions of people across the world. The new digital initiative seeks to deepen that engagement within India by encouraging people to move beyond symbolic participation and experience yoga as a consistent part of everyday living.

For Free Yoga until June 21, register here - moa.habit.yoga or call on the toll-free 1800-315-2008.

Link to Message from Sh. Prataprao Jadhav, Union Minister of State (Independent Charge) for Ayush in India - www.youtube.com/watch?v=YqezzyXjfkU

From L to R: Amrit Ravi, VP Dr. Morepen Group and G Viswanathan, Founder & Chancellor VIT

The initiative marks the launch of a new healthcare model designed specifically for educational institutions with Dr. Morepen planning similar Health Centres across universities, schools and corporate campuses throughout India.
 

Dr. Morepen Health Centre, VIT Bhopal

Dr. Morepen will manage and enhance the on-campus healthcare infrastructure through:

• Comprehensive Medical Consultations

• Day Care Centre & Minor Procedures 

• Emergency Care Support (Non-Critical)

• Advanced On-Campus Pathology & Diagnostics

• Dedicated Pharmacy and Healthcare Access

• Preventive Health Check-ups & Wellness Programs

• Student Health Awareness and Lifestyle Initiatives

Speaking on this MoU, Dr. G. Viswanathan, Founder & Chancellor, VIT Group of Institutions, renowned educationist, institution builder and former two-time Member of Parliament, said, "I am happy that today the VIT Bhopal University has signed a MOU with Dr. Morepen Health Centre. This is going to be an occasion where Dr. Morepen Centre will take care of their health, not only the students, but also the teachers, non-teaching staff and their families. We have more than 17,000 students studying there and they are from various parts of India. Now we have to take care of their health."

Dr. Morepen Home currently serves more than 4,000 families across Delhi NCR, delivering trusted healthcare services directly to patients at home including doctor consultations, nursing care, vaccinations, IV therapies and long-term family care programs.

Abhishek Bhayana, Founder, Dr. Morepen Home, said, "Dr. Morepen Home was built on a simple idea: quality healthcare should reach people where they are. Thousands of families trust us for healthcare at home and we are proud to bring that same standard of care to VIT Bhopal. This is the first of many Dr. Morepen Health Centres we plan to establish across universities, schools and offices across India."

A dedicated pathology lab and pharmacy within the Health Centre will strengthen access to essential healthcare services for students.

Amrit Ravi, Lead - Emerging Opportunities, Vice President, Dr. Morepen Group, said, "Bringing diagnostics directly to campus means earlier detection, better prevention and healthier communities."

The VIT Bhopal Health Centre marks the first step towards building a nationwide network of Dr. Morepen Health Centres across educational institutions in India.

About Dr. Morepen
Dr. Morepen Group is a leading healthcare and wellness brand with over four decades of expertise across medical devices, consumer wellness products, pharmaceuticals, diagnostics and APIs. With a strong global footprint spanning 82+ countries and globally approved manufacturing infrastructure, Dr. Morepen continues to focus on innovation, accessibility, preventive healthcare and technology-led wellness solutions designed to improve everyday health outcomes.

About VIT Bhopal University
VIT Bhopal University, established in 2017 in Madhya Pradesh, carries forward the legacy of the VIT Group of Institutions. Spread across a 300-acre green campus, the university offers undergraduate, postgraduate and doctoral programs across engineering, management, sciences and allied disciplines. Known for its technology-driven learning ecosystem, strong industry partnerships and research-focused approach, VIT Bhopal is committed to creating future-ready professionals through innovation, experiential learning and academic excellence.

For partnership or any other inquiries regarding Dr. Morepen Health Centres for universities, schools and corporates, contact: care@drmorepenhome.com 

Mr Rajit Mehta, MD & CEO, Antara Senior Care, said, “This is a very welcome step by the Noida authorities. We would want to thank the authorities for granting this and the Hon’ble Supreme Court for supporting our requests. The residents are all seniors who have booked units at Antara Noida with great interest and expectations. Our team is actively reviewing the conditions laid down in the OC, and we expect to start the process of grant of possession to the residents very soon.”

This OC unlocks approximately INR 150 crore in receivables that were contingent on possession. The total development spans approximately 12 lakh sq. ft. (1.11 lakh sq. mt.), of which Phase I accounts for approximately 7.45 lakh sq. ft. (0.69 lakh sq. mt.) and Phase II for the remaining 4.55 lakh sq. ft. (0.42 lakh sq. mt.). Total revenue for Phase I stands at approximately INR 550 crore, while Phase II is expected to generate approximately INR 800 crore. With Phase I on the path to possession, the Company will actively pursue the revalidation of approvals for Phase II.

This resolution had been pending due to a sector-wide requirement for the collective completion of shared sports facilities across Sector 150 in Noida. The Company had completed its designated contribution to the sports facilities and fulfilled all its payment obligations. To expedite the possession for its residents, the Company approached the Noida Authority and subsequently the courts, including the Hon'ble Supreme Court of India, to establish that its obligations had been fully and duly discharged and that the OC should be granted without any further delay. A partial OC has now been granted based on the Company’s demonstrated compliance.

Antara Noida Sector 150 community is designed for seniors seeking an independent and active lifestyle, offering fully finished senior-friendly residences integrated seamlessly with wellness, round-the-clock medical assistance and emergency services – in keeping with Antara's commitment to empowering seniors to age with dignity, comfort, and in a community of like-minded individuals.

About Antara Senior Care
Launched in 2013, Antara is the senior-care business of Max India Limited, part of the USD 7-billion Max Group. It is an integrated ecosystem for senior care, operating in two main lines of business – Residences for Seniors and Assisted Care Services. Antara’s first senior residential community in Dehradun, comprising nearly 200 families, caters to their social, recreational, educational, wellness, and health-related needs. In the near future, it will open its second senior living community in Noida’s Sector-150, with families moving into the 340 apartments built in the first phase. Expanding its footprint in Gurugram, Antara will manage senior living residences, dedicated spaces for senior living, and primary healthcare services at Estate 360 and Estate 361, developed by Max Estates. Antara’s Assisted Care Services include Care Homes, Care at Home, AGEasy, and Antara Integrated Wellness Clinic. This line of business caters to seniors, who need more immersive interventions in their daily lives due to medical or age-related issues. With eight facilities and 485 beds across Gurugram, Noida, Bengaluru and Chennai, Care Homes provide long-term care to seniors who require constant medical and nursing supervision, and short-term care services for the recuperation of seniors. Its Care at Home services, offered in Delhi NCR, Bengaluru and Chennai, provide well-equipped, trained professionals offering care to seniors inside their home’s comfort. AGEasy, an online and offline store focusing on senior-specific products and solutions to manage chronic health conditions at home, has touched over 6.5 lakh lives since inception in 2023.

In a remarkable medical milestone for Puducherry, East Coast Hospitals has successfully performed what is believed to be the youngest kidney transplant carried out in the region so far, completely free of cost.
 

Youngest Free Kidney Transplant recipient in Puducherry
 

This achievement was made possible with the support of the Dr. Blue India Foundation and further strengthens East Coast Hospitals’ reputation as the private hospital in Puducherry that has performed the highest number of ethical, legally compliant, and fully transparent kidney transplants.
 

Eleven-year-old Guruprasad’s story is one of quiet resilience. Raised along with his two siblings by his mother—who herself lives with significant medical disabilities—the family has been surviving on her modest disability pension, facing life’s challenges with courage and determination. Their journey took a difficult turn when Guruprasad was diagnosed with severe kidney failure, bringing immense emotional and financial strain.
 

In a powerful act of maternal love, his mother chose to donate her kidney to save her son’s life.
 

The transplant was successfully performed at East Coast Hospitals under the guidance of Dr. N. Murugesan, a distinguished nephrologist who was part of the medical team that accompanied former Tamil Nadu Chief Minister M. G. Ramachandran to the United States for treatment. The hospital continues to maintain a strong track record in kidney transplants while adhering strictly to all legal and ethical frameworks.
 

Today, Guruprasad is recovering well and looking forward to a healthier future.
 

Speaking on the occasion, Dr. Venkatram, who headed the team, expressed heartfelt gratitude to the benefactors. “Their selfless act has brought new life to this young boy and immense relief to his family,” he said. He also acknowledged the support extended by others who have contributed towards the family’s ongoing needs, including medicines, food, and clothing.
 

The transplant was made possible through the generous support of Mr. Vinayagam, Chennai Silks, and a Malaysian business couple, Datuk Dr. Ravee and Datin Kavery, who contributed through the Dr. Blue India Foundation, enabling the procedure to be carried out free of cost.
 

Dr. Venkatram further added, “There are many more families like Guruprasad’s who need timely medical intervention and support. We welcome both deserving patients and compassionate individuals who wish to make a difference to come forward and connect with East Coast Hospitals.”
 

East Coast Hospitals is also in the process of expanding its transplant services under various government healthcare schemes, including CMCHIS, PMJAY, ESI, and ECHS, with the aim of making advanced treatments more accessible and affordable to a wider section of society.
 

This story stands as a testament not only to medical excellence, but also to the extraordinary power of human compassion—where science, sacrifice, and kindness come together to give life a second chance.

Basic Life Support and Automated External Defibrillator (AED) awareness and training program
 

Kauvery Hospital had donated AED devices to Southern Railway in the past to strengthen emergency response preparedness at the railway station.
 

The training program will equip the railway staff to effectively use AEDs to provide immediate assistance during critical medical situations.
 

The program was led by Senior Doctor, Emergency Medicine, who provided practical training and demonstrations on the usage of AED machines and Basic Life Support techniques during emergency situations.
 

The session focused on creating awareness about immediate lifesaving measures that can be performed before advanced medical care arrives.
 

Dr. Lakshmanan, Medical Administrator of Kauvery Hospital, Tirunelveli, spoke about the importance of emergency preparedness and timely response in public places such as railway stations.
 

Railway Chief Medical Officer Dr. Raja Gobalan, along with the Railway Station Master and Railway Station Manager, attended the event and extended their full support in organising the program and ensuring the active participation of the railway staff members.

Adult Vaccination Clinic inaugurated at Fortis Hospital Mulund by (L-R) Dr S Amey, chief guest Padma Shri Dr Himmatrao Bawaskar, Dr K Sabnis, Dr V Beri, Dr S Narayani and Dr S Gore

The clinic addresses the growing yet often overlooked need for adult immunization, offering comprehensive vaccination counselling, risk assessment, and immunization services — all under one roof. It seeks to build awareness about the critical role vaccines play in protecting adults from diseases such as Influenza, Pneumonia, Hepatitis B, Shingles, Tetanus, HPV, and other infections that can significantly impact adult health and quality of life.

While vaccination is commonly associated with childhood immunization, adults too remain vulnerable to several infectious diseases due to waning immunity, ageing, chronic illnesses, occupational exposure, travel requirements, and compromised immune systems. The clinic will offer personalized vaccination recommendations based on an individual's age, health status, lifestyle, travel plans, and medical history.

Speaking at the launch, Dr. Kirti Sabnis, Consultant - Infectious Disease Specialist, Fortis Hospital Mulund, said, “Strikingly, in India, 95% of deaths related to vaccine-preventable diseases occur in adults! Adult vaccination remains one of the most underutilized preventive healthcare measures in India. Many adults are unaware that protection from certain diseases declines over time and that vaccination continues to be important throughout life. Our Adult Vaccination Clinic has been designed as a one-stop destination where individuals can receive expert guidance on recommended vaccines and get vaccinated conveniently in the same visit. Through this initiative, we hope to improve awareness, increase vaccine uptake, and support healthier ageing.”

The clinic will also cater to individuals with special healthcare needs, including patients undergoing organ transplantation, bone marrow transplantation, cancer treatment, or those living with chronic medical conditions that may require tailored immunization schedules.

Dr. Vishal Beri, Facility Director, Fortis Hospital Mulund, said, "At Fortis Hospital Mulund, we believe that the future of healthcare lies not just in treating medical concerns, but in preventing them. The launch of the Adult Vaccination Clinic is an important step towards strengthening preventive healthcare in our community and empowering individuals to take proactive measures to protect their health. As life expectancy increases and chronic diseases become more prevalent, adult immunization assumes greater significance in reducing disease burden, preventing complications, and promoting healthy ageing. Through this initiative, we aim to make evidence-based vaccination services more accessible while fostering greater awareness about the role of immunization across every stage of life."

Commenting on the importance of adult immunization, Padma Shri Dr. Himmatrao Bawaskar who joined in as the chief guest, said “Preventive healthcare is the cornerstone of a healthier society. Adult vaccination is a powerful yet often overlooked intervention that can prevent serious illnesses, reduce hospitalizations, and improve quality of life. Initiatives such as dedicated vaccination clinics play a crucial role in creating awareness and making preventive care more accessible to the community.”

Dr. S. Narayani, Business Head – Fortis Hospitals Maharashtra, said, "In India, while childhood vaccination has significantly improved public health outcomes, awareness around adult vaccination continues to remain limited. Through the launch of the Adult Vaccination Clinic at Fortis Hospital Mulund, we aim to bridge this gap by making expert guidance and access to vaccines more convenient. As healthcare rapidly shifts towards prevention, initiatives like these play a critical role in reducing the burden of infectious diseases, preventing complications that arise from gaps in adult immunity, and ensuring that people live not just longer, but healthier, more protected lives.”

The Adult Vaccination Clinic will function from Monday to Saturday between 12:00 PM and 5:00 PM at Block A, OPD Area, Fortis Hospital Mulund, and will offer walk-in consultations, counselling, and vaccination services.

As India continues to focus on preventive healthcare and disease prevention, the launch of the Adult Vaccination Clinic marks an important step toward improving adult immunization coverage and strengthening community health outcomes.

About IHH Healthcare
IHH is a leading multinational healthcare provider shaping the future of care. Driven by our aspiration to Care. For Good., we unite medical excellence and innovation, pushing boundaries through our trusted brands such as Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway and Prince Court. Across 10 countries, including Malaysia, Singapore, Türkiye, India and Greater China, our 70,000-strong team delivers world-class excellence every day, within and beyond our 140 healthcare facilities, including more than 80 hospitals. Our comprehensive services span the full healthcare continuum, from primary and ambulatory to quaternary care, complemented by diagnostics, imaging, rehabilitation, telehealth and home care. In partnership with our stakeholders, IHH is advancing value-based care, building a sustainable healthcare ecosystem and creating meaningful impact, as we work towards our vision to become the world’s most trusted healthcare services network. www.ihhhealthcare.com.

Upgraded Emergency Department unveiled at Fortis Hospital Kalyan by (L) Dr Pate, Dr Manoj, Dr Patil, Dr Pandey, KDMC’s Mr Goel (IAS), Dr S. Narayani, Dr Gore & Dr Mahajan
 

Over 20 years, the specialists at Fortis Hospital Kalyan’s Emergency Department managed over 60,000 emergencies. The department's emergency case mix includes 33% medical emergencies, 31% cardiac emergencies, 24% surgical emergencies, and 12% neurological emergencies reflecting the full spectrum of regional emergencies. Every case has contributed to a growing understanding of how emergencies unfold in this region, this includes insights into when they peak, how they present, and how fast they escalate. This extensive clinical experience has shaped the redesign of the new Emergency Department, prioritizing rapid triage, bedside diagnostics, and multidisciplinary coordination during time-sensitive situations.

The upgraded department's four emergency beds and one negative pressure isolation room are designed to handle the full spectrum of emergencies. The resuscitation bays are each equipped with continuous cardiac monitoring, ventilation, and defibrillation capabilities. Direct connectivity to the Cath Lab and ICU ensures that every critical intervention begins at the bedside, not after a transfer. The department is further supported by a digital triage system with a real-time bed management dashboard to improve emergency response efficiency.

The Emergency Department brings together emergency specialists, cardiologists, neurologists, trauma experts, and critical care specialists to manage a wide spectrum of emergencies including heart attack, stroke, trauma, septic shock, Pulmonary Embolism, snake bite, rail/ road trauma, cardiac arrest, etc.

Matching the ambition of the upgraded department, Fortis Hospital Kalyan simultaneously announced Code QRT 2.0, an initiative that takes emergency preparedness beyond the hospital walls and into the city. The first phase of Code QRT, hosted in 2025, trained primary care physicians across Kalyan-Dombivali to identify and stabilise critical patients before transfer. Code QRT 2.0 takes that foundation and builds a network around it. Fifteen key hospitals across Kalyan-Dombivali, identified by Fortis Hospital Kalyan, will now be a part of a coordinated emergency response system, connecting emergency physicians, specialists, first responders, and neighbouring facilities into a single, seamless chain of care. The goal of the initiative is simple; no critical patient should fall through the gap between one facility & the next and receive adequate treatment within the golden hour.

Shri. Abhinav Goel (IAS), Municipal Commissioner, Kalyan-Dombivali Municipal Corporation, who graced the inauguration ceremony said, "Kalyan has always been a city of arrivals. People come here for work, for opportunity, for a better life. Today, this city is home to millions, and as it grows, it cannot have gaps in its emergency infrastructure. Fortis Hospital Kalyan has been a pillar of healthcare for two decades, and will continue to be a caregiver for the next two. Yesterday’s inauguration tells every resident, old and new, that this city is not just growing outward. It is growing stronger from within."

Speaking about the launch, Dr. Ashutosh Pandey, Facility Director, Fortis Hospital, Kalyan, said, “The launch of the upgraded Emergency Department marks 20yrs of saving and enriching the lives of people across Kalyan. Over the years, emergency care requirements across the region have evolved significantly, both in scale and complexity. The upgraded department reflects every lesson we’ve learned and is built for speed and precision. Code QRT 2.0 multiplies those learnings across 15 partner hospitals the Kalyan-Dombivali region, creating a network where emergency stabilisation, referral, and access to definitive care happen without delay. Together, these two initiatives represent our strongest commitment yet to the communities we serve."

Commenting on the hospital’s departments clinical outcomes, Dr. Sudhir Gore, Head – Trauma & Emergency Services, Fortis Hospital, Kalyan, said, “Every design decision in this department traces back to a real patient, a real emergency, and a real lesson. Over the years, our teams have consistently focused on building a protocol-driven emergency response system to deliver outcomes exceeding international benchmarks. We have achieved door-to-balloon times as low as 28 minutes in a patient that had suffered a heart attack, against the global benchmark of 90 minutes. Similarly, we have achieved door-to-needle time of 15 minutes in a patient who had suffered a stroke.” 

Highlighting the larger vision behind the expansion, Dr. S. Narayani, Business Head – Fortis Hospitals Maharashtra, said, “Kalyan is one of the fastest growing urban centres in this region, and Fortis Hospital Kalyan is growing with it. Yesterday's inauguration is the beginning of the next chapter of healthcare in the city. Emergency care is where hospitals prove their commitment, and we intend to keep ours for the next two decades as well."

The inauguration also featured leading specialists associated with the hospital’s emergency response ecosystem, including Dr. Zakia Khan, Director – Interventional Cardiology; Dr. Rakesh Lalla, Additional Director – Neurology; Dr. Vivek Mahajan, Director – Structural Cardiology; and Dr. Manoj Kumar, Consultant – Emergency Medicine, Dr Sandeep Patil – Chief Intensivist, alongside the hospital’s emergency and critical care leadership teams. For nearly two decades, Fortis Hospital Kalyan has ensured that patients with critical emergencies does not have to leave the city to seek medical intervention. With Code QRT 2.0 Fortis Hospital Kalyan brings advanced emergency intervention closer to of communities that need it.
 

About IHH Healthcare (IHH)

IHH is a leading multinational healthcare provider shaping the future of care. Driven by our aspiration to Care. For Good., we unite medical excellence and innovation, pushing boundaries through our trusted brands such as Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway and Prince Court. Across 10 countries, including Malaysia, Singapore, Türkiye, India and Greater China, our 70,000-strong team delivers world-class excellence every day, within and beyond our 140 healthcare facilities, including more than 80 hospitals. Our comprehensive services span the full healthcare continuum, from primary and ambulatory to quaternary care, complemented by diagnostics, imaging, rehabilitation, telehealth and home care. In partnership with our stakeholders, IHH is advancing value-based care, building a sustainable healthcare ecosystem and creating meaningful impact, as we work towards our vision to become the world’s most trusted healthcare services network.

For more information, please visit www.ihhhealthcare.com.

Access Life, a joint initiative of MAHE & Chellaram Foundation, was inaugurated on May 23, 2026, at Manipal, Karnataka
 

The center was inaugurated on 23rd May 2026 at the MAHE Campus, Manipal. The inauguration was presided over by Dr. H S Ballal, Pro-Chancellor, Manipal Academy of Higher Education, with Dr. Ashok Gavande, Philanthropy India Lead, Chellaram Foundation, Mumbai, as the Chief Guest, and Dr. Anand Venugopal, Chief Operating Officer, Manipal Academy of Higher Education, as the Guest of Honor. The event also saw the presence of; Dr. Avinash Shetty, Medical Superintendent, Kasturba Hospital, Manipal; Dr. Anil K Bhat, Dean, Kasturba Medical College, Manipal; Mr. Harinarayan Sharma, Chief Executive Officer, Manipal Foundation and, Dr. Vasudeva Bhat K, Professor & Head, Department of Pediatric Oncology, Kasturba Medical College & Hospital, MAHE, Manipal; Mr Girish Nair Founder & Chairman and Mr Ankeet Dave, Co-founders & Executive Director of Access Life Assistance Foundation were present on the occasion.
 

The newly launched 10-unit facility has been specially designed for children undergoing Bone Marrow Transplant procedures, where maintaining a safe, hygienic, and controlled environment is critical due to severely compromised immunity levels during treatment and recovery.
 

This marks Access Life’s second centre in collaboration with Manipal Academy of Higher Education (MAHE), further strengthening the shared commitment towards holistic paediatric cancer care and family support services beyond hospital infrastructure.
 

The initiative is also supported by Chellaram Foundation, a global not-for-profit organisation focused on long-term, impact-driven philanthropy across healthcare, education, humanitarian aid, and child welfare initiatives.
 

Sharing thoughts on the collaboration Chellaram Foundation said, “Access Life Foundation stands out for its deeply compassionate and highly organized approach toward supporting children and families battling cancer. Their commitment goes far beyond providing accommodation—it creates dignity, stability, and hope during some of the most difficult moments in a family’s life. At Chellaram Foundation, we value institutions where compassion is matched by accountability, and Access Life exemplifies both. We are confident that every contribution made toward their mission translates into meaningful and lasting impact.”
 

Dr. H. S. Ballal, Pro Chancellor, Manipal Academy of Higher Education, said, “At MAHE, we have always believed that healthcare goes beyond medical treatment. Supporting children and families during difficult times is deeply aligned with the values and vision of our founder, Dr. TMA Pai, who believed that compassionate and accessible healthcare should reach every section of society. We are happy that MAHE could support this meaningful initiative by providing the space for the center, which will help create a safe and caring environment for children undergoing Bone Marrow Transplant treatment. This collaboration reflects MAHE’s larger commitment towards holistic and humane healthcare, where medical excellence is complemented by emotional, social, and family support systems. Facilities like these significantly reduce the burden on families while helping children continue their treatment and recovery with dignity. We appreciate the efforts of Access Life and Chellaram Foundation in strengthening paediatric cancer care support services in Manipal.”
 

Speaking about the initiative, Girish Nair, Founder & Chairman, Access Life Assistance Foundation, said, “This second centre at Manipal Academy of Higher Education marks another important milestone in our journey of ensuring that no child is forced to discontinue cancer treatment because of non-medical challenges such as accommodation, nutrition, or distance from the treating hospital.
 

We are deeply grateful to MAHE for once again extending their support by providing the space free of rental, reflecting a strong institutional commitment toward paediatric cancer care beyond hospital walls. We are equally thankful to Chellaram Foundation for supporting this initiative and believing in our vision of holistic childhood cancer care.
 

Since the inauguration of our first 12-unit centre in Manipal in April 2022, we have supported nearly 350 beneficiaries. With this second centre, we hope to extend this support to many more underprivileged families, helping children not only complete their treatment with dignity, but also recover in a safe, caring, and family-friendly environment.”
 

Dr. Vasudeva Bhat K, Professor & Head, Department of Pediatric Oncology, Kasturba Medical College & Hospital, MAHE, Manipal mentioned that, “The new centre further reinforced the departments mission of reducing treatment abandonment and refusal among children with cancer and other serious blood related disorders by addressing the social and logistical barriers that often impact continuity of care thus providing complete holistic care.”

About Access Life

Access Life is a non-profit organisation incorporated under Indian law, established in 2014 to support children from underprivileged backgrounds undergoing cancer treatment. It provides free accommodation, nutrition, transportation, counselling and non-formal education to children and their caregivers who travel from across India to major cities for treatment.
 

With 14 centres across 10 cities, Access Life supports up to 228 families simultaneously, offering a safe, nurturing environment focused on healing and stability. The organisation is registered under 80G, 12A, CSR-1 and FCRA, and has to date supported more than 10,500 beneficiaries across India.
 

About Manipal Academy of Higher Education

Manipal Academy of Higher Education (MAHE) is an Institution of Eminence Deemed to be University. MAHE offers over 400 specialisations across the Health Sciences (HS), Management, Law, Humanities & Social Sciences (MLHS), and Technology & Science (T&S) streams through its constituent units at campuses in Manipal, Mangalore, Bengaluru, Jamshedpur, and Dubai. With a remarkable track record in academics, state-of-the-art infrastructure, and significant contributions to research, MAHE has earned recognition and acclaim both nationally and internationally. In 2020, the Ministry of Education, Government of India, awarded MAHE the prestigious Institution of Eminence status. Currently ranked 3^rd in the National Institutional Ranking Framework (NIRF) 2025 rankings, MAHE is the preferred choice for students seeking a transformative learning experience and enriching campus life, as well as for national and multinational corporations seeking top talent.

Dr. Krishna Mohan Yarlagadda is a distinguished Robotic, Laparoscopic, Bariatric, and GI Surgeon with over 28 years of clinical practice in Hyderabad

Obesity is no longer viewed merely as a cosmetic issue. It is now recognized as a chronic medical condition closely linked to several serious diseases, including type 2 diabetes, hypertension, heart disease, sleep apnea, fatty liver disease, joint disorders, infertility, hormonal imbalance, and reduced mobility. Beyond physical health, obesity often impacts emotional well-being, confidence, social participation, and overall quality of life.

Dr Krishnamohan Yarlagadda - Chief Director and Senior Consultant Robotic, Laparoscopic, Bariatric, and GI Surgeon at Amor Hospital, Hyderabad states that, “The rising burden of obesity in India is becoming a major public health concern, with increasing links to diabetes, heart disease, hypertension, and reduced quality of life. Bariatric surgery has emerged as an effective and scientifically proven solution for individuals struggling with severe obesity, particularly when conventional weight-loss methods fail. With advancements in minimally invasive techniques and comprehensive post-operative care, patients today are experiencing safer procedures, faster recovery, and significant long-term health improvements.”

“In my clinical practice, I have obsevered many individuals struggling with obesity often spend years attempting weight loss through diets, exercise routines, medications, and lifestyle modifications, only to experience temporary or unsustainable results. Unfortunately, social stigma, misinformation, and the misconception that obesity is solely a matter of self-control frequently delay timely medical intervention,” he adds. Some people even trying medications without having proper understanding. One  must get tested for pancreatitis, thyroid status and visual health issues before taking these Weightloss drugs. They do have side effects and these drugs can be effective for  Weightloss maximum 15 kg usually in chosen few people under medical supervision and whenever they stop medication, there is possibility of getting back all the lost weight. A 150 kg person with or without comorbidities by losing 15 or 20 kg is not achieving the optimal weight with those medications. Bariatric Surgery, for sure, helps those people to loss weight efficiently and scientifically.

 As obesity-related disorders continue to rise, there is growing awareness regarding scientifically supported treatment approaches that focus not only on weight reduction but also on improving long-term metabolic health. Over the years, bariatric surgery has evolved considerably with advancements in minimally invasive laparoscopic techniques, surgical technologies, anaesthesia, and post-operative care.

Modern bariatric procedures such as sleeve gastrectomy and gastric bypass are designed to support sustainable weight loss while improving metabolic functioning. These procedures help reduce stomach capacity, regulate hunger-related hormones, and improve obesity-associated medical conditions. Importantly, bariatric surgery today is increasingly focused on enhancing overall quality of life, mobility, energy levels, and long-term health outcomes.

Advancements in laparoscopic and minimally invasive surgery have significantly improved patient safety and recovery. Reduced surgical trauma, shorter hospital stays, lower post-operative discomfort, and faster return to daily activities are among the key benefits seen with modern bariatric care. Additionally, structured nutritional counselling, lifestyle guidance, psychological support, and long-term follow-up programs are playing a vital role in ensuring successful outcomes after surgery.

One of the most remarkable transformations observed after bariatric surgery is the improvement in obesity-related health conditions. Many patients experience better diabetes control, improved blood pressure, relief from joint pain, improved sleep quality, enhanced mobility, and greater confidence following significant weight loss.

Health experts emphasize that delaying treatment for severe obesity may increase the risk of long-term complications and irreversible health damage. Early medical evaluation and timely intervention can help improve both physical and emotional well-being while reducing the growing burden of obesity-related diseases in India.

At the same time, maintaining balanced nutrition, regular physical activity, and healthy lifestyle habits continues to remain essential for long-term metabolic health. Understanding obesity as a medical condition rather than a personal failure is crucial in encouraging individuals to seek timely support and appropriate treatment.

With continuous advancements in bariatric care, modern weight-loss surgery is helping many patients move beyond obesity-related complications and regain healthier, more active, and confident lives.

Mohammed Ilias appointed AHMP India Chairman

Mohammed Ilias, Founder & Director of BCC Healthcare and a Chief Brand Strategist, brings over 17 years of experience in healthcare branding and strategic communication. Having worked with more than 450 hospital brands across India and international markets, he is widely recognised for championing ethical and patient-centric marketing practices in the healthcare sector.

Commenting on the announcement, Akhil Dave, Founder & Chairman of AHMP India Foundation, said, “AHMP was founded with the vision of fostering professionalism, ethical practices, and meaningful collaboration in healthcare marketing, while strengthening and elevating India’s healthcare marketing ecosystem. We believe Mohammed Ilias’ leadership as Chairman of the National Core Committee will further accelerate AHMP’s mission of building a scalable and ethical healthcare marketing community. His leadership will play a key role in building stronger industry-academia partnerships, promoting professional development, and nurturing the next generation of healthcare marketing leaders across the country.”

“Furthermore, his appointment as Chairman reflects AHMP India Foundation’s commitment to experienced, visionary, and value-driven leadership at a time when the healthcare industry is undergoing rapid transformation driven by digital innovation, evolving patient expectations, and growing awareness around ethical healthcare communication,” he added.

National Core Committee 2026–2028

Alongside Chairman Mohammed Ilias, the newly formed committee includes experienced leaders from across the country:

Convener
Kapil Pandya – Group Head, Healthcare Communication, Branding & Strategy, Krish Heart Care

National Leads

• Dr. Sumit Kapadia – National Lead, Clinician Partnerships

• Rajarajan S – National Lead, Healthcare Marcom Organisations

• Raju Parekh – National Lead, Healthcare Allied Services

• D S Chakravarthi – National Lead, Healthcare Organisations

• Ekta Modi – National Lead, Academic Partnerships

• Mahender Pala – National Lead, Healthcare Consulting Partnerships

• Chitra Baskar – National Lead, Emerging Marketeers

This diverse leadership team represents a powerful blend of clinical expertise, operational leadership, academic insight, and marketing excellence.

About AHMP India Foundation

The Association of Healthcare Marketing Professionals (AHMP) India Foundation is a dedicated platform committed to advancing healthcare marketing through ethical practices, knowledge sharing, collaboration, and professional development. By bringing together professionals from across the healthcare ecosystem, AHMP aims to build a unified, informed, and forward-thinking community that drives meaningful impact in healthcare communication and patient engagement.

India’s healthcare marketing ecosystem is rapidly evolving, yet it continues to face several critical challenges, including the lack of structured education in ethical healthcare marketing, limited platforms for professional knowledge exchange, and the increasing complexity of digital healthcare communication. AHMP India Foundation was established to bridge these gaps and has since grown into a strong network of over 10,000 professionals, bringing together clinicians, marketers, administrators, and consultants from across the healthcare industry.

The Women’s Hospital, city’s first multispeciality hospital dedicated exclusively to women, is now open at R-1, Nehru Enclave, Outer Ring Road, New Delhi. Founded by Ms. Anika Parashar and her founding team, the hospital has been established with an investment by The Select Group, and other investors, with The Select Group being the principal investor. The Women’s Hospital (TWH) has been created to address one of the biggest gaps in Indian healthcare: the absence of one trusted, judgment-free, multispeciality space that understands women’s health as a lifelong journey.

Key dignitaries at the launch of The Women’s Hospital (TWH) in Nehru Enclave, New Delhi
 

The launch was graced by Chief Guests Mrs. Jyotsana Sharma, Mrs. Saroj Singh and Mrs. Mala Baijal. Spread across 30,000 sq. ft., this state-of-the-art facility brings together clinical care, preventive health, diagnostics, holistic wellness, aesthetics and life-stage clinics under one roof. The hospital has been designed for girls and women across every phase of life, from a teenager trying to understand her first period, to a woman navigating PCOD, fertility, pregnancy, postpartum recovery, menopause, cancer screening, metabolic health, ageing, emotional wellbeing or cosmetic care.
 

The need for such a model is urgent because women’s healthcare in India can no longer be viewed through one or two touchpoints alone. With approximately 355 million menstruating women, around 23 million girls dropping out of school due to lack of menstrual hygiene, nearly 60,000 cervical cancer deaths reported annually, 25% of Indian women estimated to be affected by PCOD/PCOS, and 1 in 6 Indian couples affected by infertility, the gaps are visible across every life stage. These are not isolated concerns. They point to the need for dedicated clinics that can support women through all stages.
 

TWH addresses these concerns and aims to move women’s healthcare beyond delayed, episodic and fragmented treatment. Its model is rooted in care from menarche to menopause and beyond, with dedicated clinics for Menarche & Adolescence; Reproductive Years & Fertility; Pregnancy, Birth & Newborn Care; Early Motherhood & Postpartum; Midlife & Menopause; Chronic & Metabolic Health; Cancer Screening, Treatment & Survivorship; Cosmetic and Aesthetic Care; Care for Golden Women; and Mental Health, Nutrition & Functional Medicine.
 

Speaking on the launch, Anika Parashar, Founder & CEO, The Women’s Hospital, said, “TWH comes from a gap I have seen in over 25 years of working closely with women, families, doctors and healthcare teams. Women are often expected to care for everyone else, but when it comes to their own health, they are left to navigate fragmented systems, repeat their stories, delay care, or feel unheard. TWH has been built to change that. We want to create a healthcare home where a girl, a mother, a working woman, a woman in menopause, or an elderly woman can access specialised, preventive and holistic care without judgment. Every detail, from our clinical blueprint and life-stage clinics to the doctors, privacy, air quality and patient experience, has been designed to make women feel safer, supported and more in control of their health.”
 

Mr. Arjun Sharma, Chairman, The Select Group, shared, "Throughout our journey in hospitality and retail, we have always believed that the businesses that endure are those that genuinely serve people at their most human moments. The Women's Hospital is our most purposeful investment to date - not just because of the scale of the unmet need, but because of the vision Anika and her team have brought to addressing it. India has world-class hospitals, but very few spaces that truly centre the woman as a whole person across her entire life. TWH does exactly that, and I am delighted to back it."
 

The leadership team includes Ms. Anika Parashar, Founder & CEO, Mr. Gaurav Singh, Chief Operating Officer; Mr. Veneet Garg, Chief Financial Officer; Mr. Harjeet Singh, Head – Chief Administration and Projects Officer; and Ms. Shruti Saxena, Chief Experience and People Officer.
 

The hospital brings together a distinguished clinical team, including Dr. Raghuram Mallaiah, Executive Director – Neonatology; Dr. Anjila Aneja, Executive Director – Obstetrics, Gynaecology, Minimal Access and Robotic Surgery; Dr. Neena Bahl, Executive Director – Obstetrics, Gynaecology, Minimal Access and Robotic Surgery; Dr. Vijay Murthy, Executive Director – Functional Medicine; Dr. Karishma Thariani, Director – Urogynecology; Dr. Debashish Chaudhary, Director – Oncology; Dr. Surakshith TK, Director – Gastroenterology; and Dr. Gaurika Sahi, Director – Radiology.
 

The hospital’s clinical offering spans gynecology, obstetrics, neonatology and milk bank, urogynecology, IVF and reproductive medicine, mental health and counselling, breast surgery and oncology, functional medicine, cosmetic and reconstructive surgery, general surgery, gastroenterology, endocrinology, internal medicine with a women-focused approach, dermatology and aesthetics, nutrition and dietetics, and physiotherapy and rehabilitation.
 

With 34 total beds, including 12 NICU beds, TWH is equipped with 3 modular operation theatres, 3 labour delivery suites, 1 recovery room and 1 emergency bed. The hospital has also been built with deeply intentional patient-first details, including a Zero Indoor AQI environment supported by advanced air purification systems and continuous monitoring, infection-control protocols, privacy-led layouts, calming interiors and premium patient rooms.
 

TWH also brings advanced technology and care-led innovation into its clinical infrastructure, including robotic-assisted surgery, next-generation operating theatres, India’s first Korean-designed operating suite, advanced fetal medicine and high-resolution prenatal imaging, the 1788 laparoscopic platform, premium Hillrom LDR beds and India’s first fully integrated NICU powered by the GE satellite monitoring system.
 

Nutrition has also been designed as part of clinical care, with hospital menus created by clinical nutritionist Dr. Lovneet Batra and curated in collaboration with chefs. The kitchen philosophy includes therapeutic meal plans tailored to pregnancy, recovery and metabolic health, no Teflon cookware, no palm oil in food preparation and organic ingredient options wherever possible.
 

Every detail, from the clinical blueprint to the way a woman enters, waits, consults, recovers and follows up, has been designed to make care feel safer, warmer and more human.
 

Located close to Greater Kailash, Kalkaji, Saket, Panchsheel Park, Defence Colony, Swami Nagar and Hauz Khas, The Women’s Hospital aims to become a trusted healthcare home for women and families, not only in moments of illness, but through awareness, prevention, treatment, recovery and lifelong wellbeing.

Infographic - Top 5 perceived caused for high BP

The findings challenge conventional assumptions. When patients cross Tier 1 and Tier 2 cities were asked what caused their high blood pressure, 82% cited stress as the primary perceived cause, ranking above diet, genetics, and age combined. While nearly 6 in 10 say poor sleep can trigger BP fluctuations. Among younger patients (25–44-year-olds), 43% described their workplace stress as very high. Poor sleep and acute stress were tied as the leading triggers for BP going out of control, each cited by 59% of respondents. Seven in ten patients who experience BP fluctuations do so every single week.

The physical toll is equally significant. 43% report frequent headaches, 29% experience anxiety and restlessness, and 18% suffer heart palpitations that nearly half describe as unbearable. For most patients, hypertension is not a condition managed with a twice-yearly doctor visit. It is the background noise of daily life.

Commenting on this, Ameve Sharma, Founder and CEO of Kapiva, said ,"This study reaffirms that India's BP crisis is as much a stress and lifestyle crisis as it is a cardiovascular one. As these numbers show, preventive health solutions and sustained lifestyle changes are becoming as important as clinical intervention. At Kapiva, we have always followed a consumer-out approach, understanding what people are going through and then building solutions around those needs. Our offerings are a direct outcome of that thinking, a formulation built not just around a diagnosis but around how people are actually living with health conditions every day."

The study also reveals a parallel care system operating quietly alongside prescription medication. 35% of BP patients are already using natural or home remedies in addition to their prescribed treatment, reaching for lemon water (71%), amla (57%), garlic (53%), and Arjun Chaal (39%). The instinct is right, but the execution faces real limits: 34% cite inconsistency and inconvenience as barriers, and 25% admit they cannot maintain the habit daily.

Critically, 60% of BP patients say they are open to trying an Ayurvedic juice for blood pressure management, a figure that rises to 73% among younger patients (25–44-year-olds).

Dr. R. Govindarajan, Chief Innovation Officer, Kapiva, added, "Hypertension today is no longer just a lifestyle condition associated with age. What we are increasingly witnessing is the impact of chronic stress, poor sleep, mental fatigue, and always-on lifestyles on cardiovascular wellness, especially among younger Indians. The study findings also emphasize the need for a more holistic approach to blood pressure management, where stress management, nutrition, sleep quality, and long-term consistency become equally important alongside medical supervision. At Kapiva, our focus has been on combining traditional Ayurvedic knowledge with standardized, research-led formulations that can support modern wellness needs in a more accessible and consistent manner."

The study was conducted in February 2026 across Tier 1 and Tier 2 cities including Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai, Kolkata, Pune, and Ahmedabad, covering equal representation of males and females with a sample size of 303 across age groups from 25 to 65 and above.

About Kapiva

Kapiva is a modern, homegrown Ayurvedic D2C brand on a mission to make evidence-based Ayurveda simple, modern, and accessible for everyday wellness. Backed by a dedicated R&D vertical of scientists and researchers, Kapiva develops authentic formulations using science-backed Ayurveda, standardised herbs, and high-quality ingredients. Kapiva has been a disruptor in the Ayurvedic industry by introducing innovation in product formats that can be easily integrated into people's daily routines. Kapiva has expanded globally with its wholly owned subsidiaries in the USA and Middle East and has a strong offline presence across 50,000+ stores in India.

Kauvery Heart City has achieved a major milestone by successfully performing the Delta region’s first renal denervation therapy, an advanced minimally invasive procedure to treat resistant hypertension, a condition in which blood pressure remains persistently high despite the use of multiple medications at optimal doses. Notably, only about 100 patients across the country have undergone this advanced therapy so far.

Kauvery Hospital, Heart City

The patient, a 55-year-old woman with hypertension, diabetes, and obstructive sleep apnea, a condition in which breathing repeatedly stops and starts during sleep due to upper airway blockage, had been fully compliant with her prescribed treatment. Despite this, her blood pressure remained dangerously uncontrolled, leading to repeated hospital admissions.

Following a detailed evaluation, she underwent renal denervation therapy. The procedure works by delivering radiofrequency (RF) energy through a catheter inserted into the renal arteries, which supply blood to the kidneys. This energy selectively disrupts the overactive nerves lining these arteries, thereby reducing the signals that contribute to high blood pressure. As a result, blood pressure can be brought under better control over time.

The intervention was carried out successfully by Dr. T. Joseph, a leading Interventional Cardiologist & Electrophysiologist, along with his team at Kauvery Heart City, Trichy. The patient is currently doing well, and her blood pressure has shown significant improvement following the procedure.

In his comments, Dr. Joseph said, “We are happy to have introduced renal denervation to the Delta region. Renal denervation represents a significant advancement in the management of difficult-to-treat hypertension and marks an important step forward in expanding access to cutting-edge cardiovascular care in the delta region.”

He added that resistant hypertension can occur due to multiple factors, including overactivity of the sympathetic nervous system, hormonal imbalances, kidney-related mechanisms, and associated conditions such as diabetes and sleep apnea. In such cases, conventional medications alone may not be sufficient to control blood pressure. If left uncontrolled, resistant hypertension can lead to serious and life-threatening complications such as stroke, heart attack, heart failure, kidney damage, and vision loss. In this case, timely intervention was critical to prevent further deterioration and repeated medical emergencies.

Dr. T. Senthil Kumar, a reputed senior cardio-thoracic surgeon, and Executive Director of Kauvery Heart City, added, “This novel therapy has already benefitted close to 100 patients across the country, and we are proud to introduce it in Trichy for the first time. Kauvery Heart City has always been at the forefront of bringing advanced medical technologies to the region, and this achievement reflects our continued commitment to delivering world-class care.”

DCDC Kidney Care receiving AACI Accreditation

The accreditation was awarded following a comprehensive evaluation of the centre’s clinical protocols, patient safety standards, infection prevention and control measures, dialysis care processes, staff competency, quality management systems, operational workflows, and continuous quality improvement mechanisms. The recognition highlights DCDC Kidney Care’s commitment to delivering internationally benchmarked renal care through advanced dialysis technology, standardized treatment protocols, and a strong patient-centric approach.

Aseem Garg, Founder, DCDC Kidney Care, said, “This achievement is a proud milestone not only for DCDC Kidney Care but also for India’s standalone dialysis ecosystem. “It reflects our unwavering commitment towards clinical excellence, patient safety, and globally benchmarked quality care. We remain focused on expanding access to affordable, high-quality dialysis services through technology integration, workforce development, and our growing network across India. This recognition supports our long-term goal of bolstering the nation's dialysis infrastructure via workforce development, technological integration, quality-driven systems, and scalable service delivery models. As we continue to raise standards for patient experience, safety, and infection control throughout our network, we are dedicated to broadening our reach through both public-private partnerships and freestanding centers.”

This global AACI accreditation for the Badarpur centre reinforces DCDC Kidney Care’s position as one of India’s leading dialysis networks and underscores its role in making advanced, affordable renal care accessible across the country. Building on its expanding footprint of centres operated through both standalone clinics and public–private partnerships, DCDC Kidney Care will continue to invest in technology, training, and quality systems that improve clinical outcomes and enhance the overall experience for patients and their families.

Through its growing network of facilities, technology-enabled monitoring systems, and organized worker training programs, the company has consistently concentrated on enhancing accessibility to reasonably priced dialysis care throughout the years, that offers both enhanced patient satisfaction and clinical excellence.

About DCDC Health Services Pvt. Ltd. (DCDC)
DCDC is a leading operator of dialysis centers across India, working through Public-Private Partnership (PPP) models with state governments to provide treatment for economically disadvantaged populations. With over 250 centers nationwide — including PPP clinics, standalone centers, and units within private hospitals — DCDC continues to expand its reach every year.

A pioneer in quality dialysis delivery, DCDC is India’s first organization to receive NABH accreditation for both standalone and PPP dialysis centers, reaffirming its commitment to safe, accessible, and patient-centric care.

Now, Rashi Chowdhary - the globally renowned nutritionist and women's hormone health expert behind the practice, is formalising the framework at the heart of her work since day one. It's called The Sync Method, and while the name is new, the methodology is not. It is the distilled product of 18+ years of clinical experience, refined across more than 20,000 women navigating PCOS, fertility challenges, thyroid disorders, postpartum recovery, perimenopause, and chronic hormonal imbalance.
 

It is also the reason Nutrition In Sync has become a go-to practice for women across India, the UAE, and internationally - who are tired of being told their labs look "normal" while their bodies say otherwise.
 

Listening to systems, not silencing symptoms

The Sync Method rests on one core idea: hormonal health doesn't live in any one organ - it lives in how the body's systems communicate with each other. Rather than treating symptoms in isolation, the framework works across the foundational pillars that drive long-term hormonal balance: gut health, blood sugar stability, liver detoxification, nervous system regulation, sleep, cycle awareness, and nutrient sufficiency.
 

Every protocol is personalised, data-led, and built to address the root cause of imbalance rather than mask the signal.
 

"For decades, women have been told to eat less, train more, and push through. That's a man's protocol on a woman's body," says Rashi Chowdhary. "Women are cyclical beings. Our hormones, metabolism, and needs shift every single week of the month. The Sync Method is what happens when nutrition finally catches up to female biology."
 

Within three months on the protocol, women routinely see testosterone, prolactin, and TSH levels move in the right direction. Cycles regulate to a healthy 28-30 day rhythm. Period pain eases, sleep deepens - and many, under medical supervision, reduce or come off long-standing medications.
 

Lakshmi Kale, Head Nutritionist at Nutrition In Sync, points to what the framework changes about how women are treated, "The Sync Method gives us something most women have never been offered before - a structured, root-cause approach that actually maps to how the female body works. But the framework alone isn't what makes it work. It's the kindness women learn to extend to themselves through it. The reason it's helped over 20,000 women isn't because it's strict or prescriptive. It's because it's gentle, it honours the body's intelligence, and it gives women permission to stop fighting themselves."

Jeanne, Head Nutritionist at Nutrition In Sync and someone who has lived with endometriosis herself, speaks to what makes the approach resonate so deeply with women, "What sets The Sync Method apart is that it doesn't ask women to override themselves. So much of conventional advice teaches women to push harder, restrict more, and ignore what their body is telling them. Our approach does the opposite - it's gentle, and it works with a woman's inner wisdom rather than against it. When women are taught to trust the signals their body is already sending, that's when real recalibration begins."
 

The shift is one clients feel quickly. Priyadarshini, a Nutrition In Sync client, saw results within her first week on the program, "Within 7-9 days on the ONE Program, my energy improved, bloating reduced, and my gut inflammation settled. The simple, sustainable diet helped me regain focus, positivity, and balance - in both my personal life and my business."
 

The Sync Method is delivered through Nutrition In Sync's flagship ONE Program, a fully virtual 1-on-1 protocol. Women can begin with the free Sync Score self-assessment to map where their imbalance is loudest.
 

About Rashi Chowdhary

Rashi Chowdhary is a globally renowned women's hormone health expert, certified diabetes educator, and the founder of Nutrition In Sync. With 18+ years of clinical experience, she has worked with women across India, the UAE, and internationally, including notable names from film, sport, and public life. She is the creator of The Sync Method and a frequent voice on leading podcasts including The Take20 with Samantha Ruth Prabhu, Rowshan, Mumkin, and Dubai One. She is also the founder of Plaay, a healthy chocolate company built on nourishment without guilt.
 

About Nutrition In Sync

Founded by Rashi Chowdhary, Nutrition In Sync is a fully virtual women's hormone and gut health practice. In four years, it has supported over 20,000 women globally in addressing PCOS, endometriosis, thyroid disorders, fertility challenges, postpartum recovery, and metabolic conditions through a root-cause, functional nutrition approach. Its flagship offerings include the ONE Program and the 15-Day Gut Cleanse.

DKMS Foundation India brings together changemakers and medical leaders at the Lifesaver Honours Night in Bengaluru to support blood cancer patients
 

The event brought together key stakeholders whose collective efforts have driven the expansion of the blood stem cell donor registry and enhanced patient care in India. It highlighted the importance of sustained collaboration across the medical community, institutions, and civil society to address the growing need for stem cell donors, while also drawing attention to ongoing efforts to raise awareness and bridge gaps in access to timely, life-saving transplants for patients across the country.

Among the prominent guests at the evening were Karthik Reddy, Joint Commissioner of Police (Traffic), Bengaluru City, and Mandira Bedi, actor, television presenter, and fitness advocate, who lent their support to the cause.

“Our mission to provide a second chance at life is a collaborative effort spanning medical science, corporate social responsibility, and public advocacy,” said Patrick Paul, Executive Chairman, DKMS India. “The Lifesaver Honours is our way of expressing gratitude to those who go above and beyond to bring hope to patients in need. Their commitment continues to form the backbone of our work in India.”

Dr. Elke Neujahr, Global CEO, DKMS said, “Every year, thousands of donor searches are initiated globally, highlighting the ongoing need for matching donors. At DKMS, we are committed to ensuring that every patient in need can find a suitable match.”

“This is only possible through collaboration. To save lives it takes voices that inspire action, institutions that mobilise communities, medical teams that deliver excellence, and individuals whose dedication never stops.”
 

A key highlight of the evening was the presentation of the Lifetime Achievement Honour to Dr. Latha Jagannathan, Medical Director and Managing Trustee, BMST Bengaluru, in recognition of her contribution to the fight against blood cancer and blood disorders. “I am deeply honoured to receive this recognition and to stand alongside those committed to this cause,” said Dr. Latha Jagannathan. “It is a privilege to contribute to work that brings hope to families when they need it most.”
 

The evening also served as a platform to discuss key challenges in blood stem cell transplantation, including gaps in donor availability, awareness, and timely access to treatment, while highlighting the need for stronger collaboration across the healthcare ecosystem to improve patient outcomes.
 

The evening honoured winners across four distinct categories:

Category 1: Awareness
Excellence in Blood Cancer & Blood Disorders Reporting: Awarded to Afshan Yasmeen, Deputy Editor, The Hindu, Bengaluru, for impactful reporting that brought the cause to the forefront of public discourse through the story, “A Silent Burden: Thalassaemia Patients in Karnataka Battle Disease with Hope and Hardship”
 

Category 2: Registration
Outstanding Institutional Partner: Recognising Manipal Institute of Technology (MAHE), Manipal, for leading the way in youth donor registration.
Outstanding Corporate Partner: Celebrating EXL Technologies, India, for integrating the DKMS mission into their CSR and employee engagement initiatives.

Category 3: Medical Excellence
Collection Centre of the Year: Awarded to BMST, Bengaluru, for demonstrating exceptional standards in donor care and stem cell collection.
Medical Advisory Group Felicitation: A special honour for 10 distinguished members of the medical community for their expert guidance.

Category 4: Special Recognition
Lifetime Excellence Award: A leadership-discretionary honour recognising an individual who has made a unique, transformative impact on the lives of patients with blood cancer and blood disorders.
 

About DKMS Foundation

DKMS Foundation, India, is a non-profit organisation dedicated to the fight against blood cancer and other blood disorders, such as thalassemia and aplastic anemia. The foundation aims to improve the situation of patients in India and across the world by raising awareness about blood stem cell transplantation and registering potential blood stem cell donors.

For more information, please visit www.dkms-India.org.

The survey, conducted by Habuild among over 5,000 respondents, the majority of whom were women, highlights a critical gap between intent and action when it comes to maternal health and well-being.

Key findings from the Habuild survey include:

• Over 60% of respondents are aged 45 and above, indicating that many women begin prioritising their health only later in life

• Nearly 59% of mothers said structured health programs would motivate them to take their health more seriously

• A significant proportion also highlighted the need for expert guidance and community support to stay consistent with their health goals

These insights underline a crucial reality: while awareness around health is increasing, mothers often delay prioritising their own well-being due to years of focusing on family responsibilities.

This also highlights a larger systemic gap—while mothers are expected to be primary caregivers, there is limited access to structured, credible, and sustained health support tailored to their needs.

Saurabh Bothra, Co-founder, Habuild

Commenting on the findings, Saurabh Bothra, Co-founder, Habuild, said, "For far too long, mothers have been conditioned to put their own well-being on the backseat while caring for everyone else. What we’re witnessing now is a powerful shift—mothers want to prioritise their health, but they need the right structure, guidance, and community to make that sustainable. At Habuild, we believe that when you empower a mother to take care of herself, you’re strengthening the entire family ecosystem. It’s time we move from simply acknowledging mothers to actively enabling their well-being."

As preventive healthcare gains importance, the findings call for a shift in how maternal well-being is approached—not just as an individual responsibility, but as a shared priority for families, communities, and healthcare providers.

For more information, please visit habuild.in.

This programme represents an important step in addressing high-risk mental health conditions, with Mpower being among the early mental healthcare providers in India to introduce a structured and evidence-based DBT programme at scale, particularly for individuals at risk of suicide and self-harm.
 

Representatives from Mpower, Behavioral Tech Institute, Marsh India, and participating clinicians during the ongoing DBT Intensive Training Programme in Mumbai
 

The initiative, which is also supported by Marsh India as part of its CSR commitment to enabling mental health initiatives in India, is being implemented through an ongoing DBT Intensive Programme in Mumbai for the first cohort, marking the beginning of a year-long structured capability-building journey aligned with global standards followed by the Behavioral Tech Institute. It goes beyond one-time training and includes foundational and advanced modules, ongoing case-based consultation, team-based learning, and real-world clinical application, ensuring sustained capability building.
 

India continues to face a significant mental health burden, with over 170,000 suicide deaths reported annually. Nearly 35-40 percent of these cases are among young people aged 15 to 29, with notable variations across gender. Despite this, access to structured and evidence-based interventions for high-risk individuals remains limited, particularly within public healthcare systems.
 

The programme has brought together leading clinicians and institutions, including NIMHANS, Punjab Health Ministry, Sion Hospital, Nair Hospital, KEM Hospital, Thane Regional Mental Hospital, Mindset Wellness, and Masina Hospital, as part of its first cohort aimed at strengthening the public healthcare system, reflecting a growing and multi-institutional commitment to building frontline clinical capacity.
 

Dialectical Behavior Therapy (DBT), developed by Dr. Marsha M. Linehan, is globally recognised for its effectiveness in reducing suicide attempts, self-harm behaviours, and psychiatric hospitalisations. Its structured and skills-based approach makes it particularly relevant for individuals experiencing severe emotional distress and those at high risk of suicide. Over the next five years, Mpower aims to build a robust network of DBT-trained clinicians and enable the adoption of structured DBT protocols across leading public and private healthcare institutions, helping to bridge the gap between clinical need and access to specialised care in India.
 

Speaking on the initiative, Mrs Neerja Birla, Founder and Chairperson, Mpower and Aditya Birla Education Trust, said, “India is at a critical inflection point in its mental health journey. While awareness is increasing, there remains a significant gap between need and access, particularly for those at high risk of suicide and self-harm. DBT represents one of the most rigorously validated therapies globally for individuals in severe emotional distress. Through this collaboration, we aim to build clinical capability, equip practitioners with structured tools, and contribute to building more responsive and resilient mental healthcare communities in India by 2030.”
 

Mr Sanjay Kedia, CEO, Marsh India and President and CEO, Marsh India Insurance Brokers Private Limited, added, “Mental health is integral to societal and economic resilience. Supporting structured and evidence-based approaches such as DBT aligns with our commitment to enabling stronger and more prepared communities.”
 

Dean Lester, CEO, Behavioral Tech Institute said, “India’s need for high-quality and evidence-based mental health interventions is both urgent and significant. Through this collaboration, we are supporting the development of clinical capabilities aligned with global standards.”
 

This programme represents an important step towards strengthening India’s mental healthcare ecosystem by building clinical capacity, enabling structured interventions, and improving outcomes for individuals at high risk.
 

About Mpower

Backed by Aditya Birla Education Trust, Mpower is a pioneering holistic mental health initiative, now marking a pioneering holistic mental health initiative marking a decade of impact in transforming mental health awareness and care in India.Since its inception in 2016, under the leadership of Mrs. Neerja Birla, Mpower has been committed to building an inclusive ecosystem where individuals and their caregivers receive professional support, compassionate care, and acceptance—free from stigma or discrimination.
 

Through a multidisciplinary and integrated approach, Mpower delivers impact across a diverse ecosystem—including clinical services, outreach and awareness programs, institutional partnerships, helplines, educational initiatives such as Minds Matter, and sports-focused interventions like AMP.
 

Over the past 10 years, Mpower has played a pivotal role in normalizing conversations around mental well-being, reaching millions through its care delivery, prevention programs, and large-scale partnerships—continuing to enable individuals to seek support with dignity, confidence, and hope.
 

For more information, please visit mpowerminds.com.

The India Mental Health Alliance (IMHA) today announced that it has crossed 300 member organisations across 30 states and union territories, marking a significant milestone for India’s evolving mental health ecosystem.
 

The India Mental Health Alliance

More than a growth milestone, the development reflects a broader shift across stakeholders towards greater collaboration, shared learning, and coordinated action for mental health, which has long operated in fragmented silos. IMHA was established on the belief that meaningful progress in mental healthcare requires bringing clinical and lived experience expertise together; aided by resource mobilization from philanthropy, government and the private sector collectively.
 

Neha Kirpal, Co-Founder, IMHA, said, “Reaching 300 members is significant because of what it makes possible for everyone. When cross-sectoral organisations have a shared alliance to connect, share on-ground learnings across their cultural contexts, and build capacities together; the entire ecosystem becomes stronger and more effective. IMHA’s role has been to act as a catalyst and facilitator, creating the possibilities for partnerships, and pathways that enable knowledge, expertise, and support to flow more freely across the nation. This kind of collaborative infrastructure is essential to move mental health from the margins to the mainstream as a developmental priority in our journey towards Viksit Bharat.”
 
Over the past year, this vision has translated into a focused effort to - Connect, Convene, Collaborate, and build Capacity across the mental health ecosystem. IMHA’s key initiatives towards these goals in this past year have included:

• A national member directory with QR-enabled discoverability tools for all members, funders and public institutions to connect with organisations from across India

• Active digital communities, including an active nationwide WhatsApp group

• Ongoing member engagement across geographies with regional meet ups

• Building members’ capacities through monthly curated sessions and consultations with global experts; themes include organisational strengthening, youth mental health, lived experience expertise, public health integration, cross-sector programming, and engagement with funders and government

Together, these efforts are helping organisations discover one another, exchange knowledge, and collaborate more effectively across the country. 

Building on these connections, IMHA has also prioritised convening as a core pillar of ecosystem-building by creating spaces for organisations to come together, exchange ideas, and forge partnerships. Through its ‘Connecting India for Mental Health’ series, IMHA hosted its first regional meet-up in Mumbai, with upcoming convenings planned in:

• Guwahati (May 2026)

• Chennai (August 2026)

• Bangalore (December 2026)

This builds on the momentum of IMHA’s first Annual Convening last year, a landmark closed-door gathering of 130+ Alliance members from across the country for deeper dialogue and partnership-building; the second edition of the Annual Convening to be announced shortly for the month of Oct/Nov 2026. 

This culture of shared learning is further anchored in IMHA’s Knowledge Centre, a hub for credible, India-specific mental health resources. The platform currently hosts 300+ curated resources, including toolkits, capacity-building materials, lived experience-led resources, laws and policies, landscape reports, and data-driven insights. Designed for NGOs, funders, policy makers, students and mental health professionals; the Knowledge Centre will now expand into video-based learning from Indian experts and increased regional language content to deepen contextual relevance.

Vasvi Bharat Ram, Founder Chairperson, India Mental Health Alliance, says, “A truly developed India must also be a mentally healthy India. Economic growth, educational outcomes, workforce productivity, and social cohesion are deeply linked to the mental well-being of citizens. Building this requires coordinated investment, long-term thinking, and shared responsibility across multiple fronts, from systemic capacity-building and workforce development to knowledge creation and improving the overall quality of care. Philanthropic capital, government funding, and private sector investment each have a distinct role to play to build a mental health ecosystem that is more accessible, resilient, and responsive to India’s needs.” 

Therefore, IMHA is actively expanding the pool of unrestricted philanthropic capital dedicated to long-term ecosystem-building in mental health, with recent pledges from donors such as Manisha Dhawan from the Convergence Foundation of India and renowned philanthropist Dr. Pheroza Godrej.

As India moves towards 2047, IMHA’s expanding strength reflects a new, decentralised approach to mental health: one rooted in equity, shared ownership, cross sectoral collaboration; with lived experience experts and their carers at the centre of all care design. 

About The India Mental Health Alliance
The India Mental Health Alliance (IMHA) is a Section 8 not-for-profit organisation launched in 2023 as a partnership between Vasvi and Ashish Bharat Ram, Amaha Health and Children First. IMHA is a cross-sectoral platform working to strengthen India’s mental health ecosystem by convening stakeholders, building capacity, and catalysing collaboration at scale. As a growing national alliance of 300 cross-sectoral member organisations from 30 states & UTs, IMHA helps mobilize existing strengths, identify care gaps, and enables stronger coordination & collaboration pan-India. Its capacity-building efforts support community organisations, healthcare & educational institutions, as well as individual mental health practitioners through multi-channel knowledge sharing and learning initiatives. IMHA also hosts a growing Knowledge Centre with 300+ multilingual resources to democratise access to mental health information. Through its work, IMHA aims to mainstream mental health as a national development priority; improve quality of care; embed Lived Experience Expertise (LEE) in care design and practice; champion social justice in mental health; and mobilise greater long-term, unrestricted philanthropic capital to support systemic, scalable solutions across India. 

Odin Buddy

Breathing treatments can often be stressful for young children and equally challenging for parents. Odin Buddy aims to change that narrative by transforming nebulization from a fearful medical routine into a friendly, engaging, and reassuring experience.

Key Highlights of Odin Buddy

• Kid-friendly, playful design to reduce fear and anxiety

• Smooth and efficient nebulization suitable for pediatric use

• Engaging add-ons like a coloring book to keep children occupied

• Compact, easy-to-use, and parent-approved

• Designed to make breathing treatments calmer, happier, and stress-free

Designed for Kids. Trusted by Parents

Odin Buddy features a playful, child-appealing design that instantly feels more like a companion than a medical device. By reducing anxiety and resistance, the nebulizer helps ensure better compliance with prescribed therapy—making treatments smoother for both children and caregivers.

To further enhance the experience, Odin Buddy comes with thoughtful add-ons such as a coloring book, helping keep children engaged and calm during nebulization. These small but meaningful touches are designed to distract, comfort, and reassure kids while they receive their medication.

Where Care Meets Compassion

“Odin Buddy reflects our belief that healthcare, especially for children, should go beyond functionality,” said Darsh Aggarwal from Dr. Odin. “We wanted to create a product that not only delivers effective nebulization but also emotionally supports children during treatment. When kids feel relaxed and happy, outcomes improve—and parents feel more at ease.”

Helping Little Ones Breathe Easy

With Odin Buddy, Dr. Odin reinforces its commitment to human-centric innovation, combining medical reliability with thoughtful design. The product is ideal for children requiringnebulization due to asthma, bronchitis, allergies, or other respiratory conditions.

Odin Buddy is now available across leading online marketplaces like Amazon, Flipkart, offline retailers, and through Dr. Odin’s brand website www.drodin.in.  

About Dr. Odin

Dr. Odin is a rapidly growing Indian home healthcare brand offering a wide range of medical devices and wellness solutions. Known for its focus on quality, innovation, and accessibility, Dr. Odin aims to bring dependable healthcare into every household.

Anurag Yadav, Chief Executive Officer – Livasa Hospitals, welcomes Mr. Kamal Kant Gambhir to the organisation as Chief Financial Officer
 

Known for building robust financial systems, driving operational efficiency, and enabling sustainable business growth, Mr. Gambhir’s appointment comes at a significant time as Livasa Hospitals accelerates its expansion plans and strengthens its commitment to quality, affordable and patient-centric healthcare.

Welcoming him to the organization, Mr. Anurag Yadav, Chief Executive Officer, Livasa Hospitals, said, “We are pleased to welcome Mr. Kamal Kant Gambhir to the Livasa family. His deep financial expertise, strategic perspective, and proven leadership track record will be invaluable as we continue to scale our network and build a future-ready healthcare institution.”

A Chartered Accountant, Mr. Gambhir is also widely respected as a mentor and motivational speaker, with a passion for developing future leaders and contributing to social welfare initiatives.

Livasa Hospitals is a multi-speciality tertiary care hospital network with 750+ beds across Mohali, Amritsar, Hoshiarpur, Nawanshahr, and Khanna. Supported by 250+ experienced doctors and 40+ super specialities, the network is committed to delivering quality, patient-centric, and affordable healthcare. With upcoming hospitals in Ludhiana and other key locations, Livasa Hospitals continues to strengthen access to advanced healthcare across North India.

Kauvery Hospital, Alwarpet

The procedure was performed on a 79-year-old patient diagnosed with severe mitral regurgitation due to a flail anterior mitral leaflet, along with atrial fibrillation and a prior history of transient stroke, placing them at high risk for heart failure and stroke.

Mitral valve regurgitation is a condition in which the valve does not close properly, causing blood to leak backward within the heart. While open-heart surgery remains the standard treatment, many elderly patients or those with multiple medical conditions are considered high risk for surgery. For such patients, minimally invasive transcatheter options like MitraClip provide an effective alternative.

MitraClip is a minimally invasive procedure in which a small clip is placed on the mitral valve through a catheter to help it close more effectively and reduce leakage—without the need for open-heart surgery.

Many of these patients also have atrial fibrillation, an irregular heart rhythm, which increases the risk of stroke due to blood clot formation in a small pouch of the heart called the left atrial appendage.

Left Atrial Appendage Closure (LAAC) is a procedure in which this pouch is sealed using a specialized occluder device, thereby preventing clot formation and reducing stroke risk—often eliminating the need for long-term blood thinners.

To address both conditions simultaneously, the cardiac team at Kauvery Hospital performed a combined procedure—repairing the leaking mitral valve using MitraClip and sealing the left atrial appendage using a specialized occluder device. Both interventions were carried out through the same access route under a single anesthesia.

This combined approach helps reduce procedural risk, shortens hospital stay, and minimizes overall treatment burden for the patient.

Following the procedure, the patient was monitored for 24 hours and discharged within 48 hours in stable condition.

Dr. Rajaram Anantharaman, Senior Consultant Interventional Cardiologist, said, “Careful patient selection and procedural planning are critical in such complex interventions. Performing MitraClip repair alongside left atrial appendage closure requires precision and coordination, but it allows us to offer a comprehensive solution in one session. For high-risk patients, this approach can meaningfully improve outcomes while minimizing complication.”

Speaking on the same, Dr Aravindan Selvaraj Co Founder and Executive Director Kauvery Group of Hospitals said, “Accurate diagnosis and timely treatment are fundamental to managing complex cardiac conditions. At Kauvery Hospital, our cardiology team stays abreast of advancements in cardiac technology and minimally invasive therapies to offer care that is safe, precise, and patient-centric. This procedure reflects our commitment to evidence-based treatment approaches that improve clinical outcomes, support faster recovery, and enhance quality of life, while bringing advanced cardiac care closer to the community.”

Orange Health Labs today announced strong financial performance for FY26, reporting ₹138 crore in revenue and exiting the year at a ₹180 crore ARR, marking a 65% year-on-year growth for both LTM revenue and ARR. With over 3 million orders served to date, the company reinforces its position as India’s fastest diagnostic lab and among the fastest-growing consumer healthcare brands in the country.

From left to right: Tarun Bhambra and Dhruv Gupta, Co-founders of Orange Health Labs

Headquartered in Bengaluru, the company has scaled its presence across Mumbai, Delhi-NCR, and Hyderabad, building a strong multi-city footprint.

Along with fast scaling, the company hit key milestones on profitability as well - it achieved 20% EBITDA profitability in Bengaluru, and became operationally profitable across all cities, underscoring its strong unit economics and a sustainable growth model.

Orange Health Labs continued to deepen its consumer promise of speed and reliability, delivering 99%+ on-time sample collection. It also scaled its omnichannel presence, from 15 stores last year to 75+ company-owned collection centres, with almost 50 stores in Bengaluru, bringing its differentiated at-home experience into physical retail.

Beyond direct-to-consumer services, the company has built a strong healthcare ecosystem. With 2,000+ clinics onboarded through its proprietary platform, it enables faster diagnosis and better clinical decision-making for doctors. 

Orange Health Labs is among the top-rated diagnostic brands in the country, with 50,000+ five-star Google reviews, reinforcing consistent consumer experience and growing brand trust. 

The company also advanced its digital innovation stack with NeO Reports which enables customers to get a quick view of their health parameters, filter, tag and share easily with their family and healthcare providers. Additionally, the company launched Orange One—a first-of-its-kind annual diagnostics plan in India - moving beyond the traditional pay-per-test model to enable proactive, long-term health management.

Commenting on this milestone, Dhruv Gupta, Co-founder, Orange Health Labs, said, “This year marks a defining inflection point for us. Delivering strong growth across all cities, alongside profitability in our home market, validates the strength of our model. More importantly, it reflects a deep and growing consumer trust in a category that has traditionally lacked it. Our focus has been simple—build the fastest, most reliable diagnostics experience—and the market is responding to that clarity.”

Adding to this, Tarun Bhambra, Co-founder, Orange Health Labs, added, “We are reimagining diagnostics as a real-time, consumer-first service—where speed, accuracy, and transparency are non-negotiable. Operational excellence, like 30-minute sample collection and 6-hour report delivery, is just the starting point. With innovations like NeO Reports and Orange One, we are moving the category from reactive testing to proactive health management at scale.”

Backed by leading global investors including Y Combinator, Accel, General Catalyst, Bertelsmann India Investments, and Amazon Sambhav Venture Fund, the company has raised a total of $50 million to date.

For more information: www.orangehealth.in

Monitra Healthcare Founders - From L to R - Sashank Bhogu, Aparna Bhogu and Ravi Bhogu
 

The round marks a strong vote of confidence in Monitra's clinical maturity, IP depth, and global ambition. When Monitra Health closed its funding round in December 2023, the story was about potential. Two years on, that thesis has been decisively validated. Monitra is no longer building the category - it is defining it.
 

Expanding clinical and commercial scale

• 50,000+ patients monitored on the upBeat® platform - a 5x jump from 10,000 at the time of the previous round, reflecting both deeper hospital adoption and broader physician preference.

• 10+ billion heartbeats analyzed, one of the largest proprietary high-resolution continuous ECG datasets.

• Revenue has grown 11x over the past four years, driven by disciplined execution, capital efficiency, and an expanding base of prescribing clinicians.

• Leading hospital adoption: trusted by marquee networks & clinicians from Manipal, Apollo, Aster and AIG, with an expanding footprint across Tier 1-Tier 4 cities in India.

A rare full-stack category position

Remote cardiac monitoring is projected to grow from USD 4.1 billion in 2024 to USD 12 billion by 2034 (11.3% CAGR, Market.us 2026). Yet the full-stack opportunity - owning the device, signal-acquisition technology, clinical reporting workflow and analytics layer - remains concentrated among a small handful of incumbents globally. Monitra is among a small group of companies globally to have built a full-stack platform end-to-end to have built that full stack end-to-end, powered by its proprietary XtremeSpan™, NanoVue™ and DeepFind™ technology and a dataset of billions of real-world heartbeats. This vertical integration drives upBeat®'s diagnostic precision, cost advantage and scalability - and makes the company structurally hard to replicate.
 

Why clinicians, hospitals, and global talent are aligning
Seasoned global medtech operators and leading cardiologists and electrophysiologists are aligning with Monitra as advisors, collaborators, and champions. For hospital systems, upBeat® is both a clinical and commercial lever: continuous monitoring captures arrhythmic events that short-duration tests miss - improving diagnostic yield, accelerating the path to the right intervention, and driving better patient outcomes - while opening a recurring, reimbursable revenue stream for cardiology service lines that scales with no proportional increase in clinician time or operational overhead.
 

The road ahead
Monitra enters its next phase of growth from a position of unusual strength for a medtech company at this stage - a proven product, growing clinical footprint, 11x revenue growth, strong IP, a maturing international regulatory pathway, and a category position rare anywhere in the world. The focus over the coming quarters is clear: accelerate global certifications, scale commercial reach within India, and continue building the clinical, scientific and organizational depth of a company operating on a global stage.
 

In their words:

“Our last round was about proving this could work. This one is about proving it can work everywhere. Crossing 50,000 patients, analyzing over 10 billion heartbeats, and growing revenue 11x has moved upBeat® from a promising platform to an indispensable one for a growing number of clinicians. We are grateful to this set of investors for backing that future with us,” Ravi Bhogu, Founder & CEO, Monitra Health.

“We are truly upBeat about our investment in Monitra Health. It is rare to find a company that combines strong IP, patented technology, cost advantage, and a world-class product built in India for global markets. With growing adoption among leading hospitals and cardiologists, Monitra has demonstrated both innovation and execution. We believe the company has the potential to become a global leader in cardiac monitoring - from India to the world,” Avinash Kalia, New Age India Fund.

“We first backed Monitra when the thesis was still being tested. Doubling down today is one of the easier decisions we have made — the clinical footprint has scaled 5x, revenue has grown 11x, the IP has deepened, and the team has stayed remarkably disciplined with capital. Monitra has exactly the kind of deep-tech healthcare solutions India should be exporting to the world,” Vasu Guruswamy, Co-founder & General Partner, Lavni Ventures.

“As practicing clinicians, we see the diagnostic gap in heart rhythm disorders every day. What Monitra has built is genuinely rare — a device and reporting workflow that is clinician-grade in accuracy, patient-friendly in design, and affordable enough to reach the populations that need it most. Global HealthX is privileged to support this team as they take it worldwide,” Dr. Ravindranath Kancherla, Global HealthX.

About Monitra Health
Monitra Health is building upBeat®, a full-stack remote cardiac monitoring platform and one of the few vertically integrated players in the global category. By owning the stack across wearable hardware, proprietary signal-acquisition technology, cloud software, analytics and clinical reporting, Monitra has created a defensible position in a fast-growing global category. Monitra's innovation is backed by patents granted in the United States, Australia and India, with additional filings underway.
 

Learn more at www.monitrahealth.com.

Dr Vivek Bose C is a highly experienced Interventional Cardiologist based in Madurai, with 25 years of clinical experience in the field of cardiology

TAVI delivers a replacement valve directly into the heart through a thin, flexible catheter, typically inserted through the groin, with no large incisions, no stopping of the heart, and no open-chest surgery. The diseased valve is gently pushed aside and the new valve begins working immediately, restoring normal blood flow and relieving the strain aortic stenosis places on the heart and body. Hospital stays are short, recovery is gentle, and patients return to daily life far sooner.

Dr Vivek Bose C, Senior Interventional Cardiologist at Apollo Speciality Hospitals, Madurai affirms, "TAVI represents a major advancement in our ability to treat high-risk cardiac patients safely and effectively."

A 73-year-old patient who underwent the procedure shared, "For months, I could not walk across the room without stopping to catch my breath. Within days of the procedure, I was walking to the garden, helping in the kitchen. I feel like myself again — like I have come back to life."

Specialists emphasise that timely evaluation is critical. Anyone experiencing persistent breathlessness, fatigue, or chest discomfort should seek cardiac assessment promptly, because with TAVI, a better quality of life is within reach.

Ms. J. Krishna Kavya Founder - Director, Athulya Senior Care with Ms. Vijaya Rao, Director, International Collaboration Office, SingHealth

SingHealth brings together an extensive network of institutions spanning acute hospitals, specialist centres, polyclinics, and community hospitals. These include Singapore General Hospital, KK Women's and Children's Hospital, Changi General Hospital, and Sengkang General Hospital, alongside national specialty centres, the National Cancer Centre Singapore, National Dental Centre Singapore, National Heart Centre Singapore, National Neuroscience Institute, Singapore National Eye Centre, and National Skin Centre, as well as SingHealth Polyclinics and SingHealth Community Hospitals.

The MoU partnership reflects a shared commitment to advancing the quality and accessibility of senior care amid growing demand driven by ageing populations. Bringing together Athulya's expertise in senior living and continuum care with SingHealth's internationally recognised clinical and academic capabilities, the partnership aims to strengthen care delivery and build institutional capacity across both organisations.

Under the MoU, both organisations will explore structured training programmes for doctors, nurses, and allied healthcare professionals, aiming to train capable professionals annually, focused on strengthening clinical competencies and caregiving standards. The collaboration will also facilitate the exchange of scientific, academic, and technical information, including relevant materials protected by intellectual property rights in accordance with agreed protocols, while enabling the identification of opportunities for joint research and development, co-authored publications, and participation in academic and scientific forums such as seminars and conferences.

In addition, the partnership will support the organisation of and participation in medical conferences, courses, workshops, exhibitions, and other forums of mutual interest, with plans to conduct joint programmes annually. It will further promote the operation of joint medical training and education programmes to raise competency levels. It will also enable the exchange of information relating to medicine, subject to confidentiality obligations, and promote ongoing engagement between the two organisations through knowledge-sharing platforms and regular interactions, including periodic bilateral meetings to review progress and expand areas of cooperation.

Speaking on the collaboration, Mr. Srinivasan G, CEO & Founder, Athulya Senior Care, said,  “This collaboration with SingHealth represents an important milestone in our journey to enhance senior care in India. By integrating Athulya’s care delivery experience with SingHealth’s clinical expertise, we aim to further strengthen our capabilities across medical services, training, and research. This partnership will support the adoption of global best practices while contributing to the development of a more robust and responsive senior care ecosystem.”

Ms. Vijaya Rao, Director, International Collaboration Office, SingHealth, said, “We are pleased to collaborate with Athulya Senior Care in exploring opportunities to advance medical services, education, and research. This partnership underscores our commitment to international collaboration and knowledge exchange. Through this engagement, we look forward to supporting capability building, sharing clinical expertise, and contributing to improved care outcomes, particularly in the area of senior and community care.”

Adding to this, Mr. London Lucien Ooi, Group Director, International Collaboration Office, SingHealth, said, “This collaboration reflects SingHealth’s ongoing commitment to building meaningful international partnerships that drive the exchange of knowledge, clinical expertise, and best practices. By working closely with Athulya Senior Care, we see strong potential to support capability development in senior care, while fostering shared learning and innovation across healthcare systems.”

The collaboration is expected to lay the foundation for sustained engagement between the two organisations, with a focus on improving care standards, advancing professional development, and enabling research-led innovation in senior care.

About Athulya Senior Care

Athulya Senior Care, India’s Largest Assisted Living Provider, headquartered in Chennai, India, with 1,500+ beds across 12+ locations in five cities Chennai, Bengaluru, Kochi, Hyderabad, and Coimbatore, has proudly served over 45,000+ seniors. Athulya delivers a comprehensive senior care ecosystem encompassing Assisted Living, Mind & Memory Care, Transition Care, Rehabilitation, and Palliative Care. Designed to meet international safety & quality standards, Athulya is transforming eldercare in India by prioritizing dignity, comfort, and compassionate support.

To know more, log onto: www.athulyaseniorcare.com.

S.L. Raheja Hospital Mumbai’s trustees & clinicians at the inauguration of advanced Histopathology Dept. & Orthopedic Robotic System, advancing precision & patient care in the city

The Histopathology Department, originally established by late Dr. Anita Borges, was relaunched in its upgraded form, seamlessly blending legacy, deep clinical, expertise & enhanced capabilities. Recognised as a coveted Centre of Excellence for Histopathology by leading cancer institutes across India and internationally, the department has, to date, analysed over 2,20,000 samples till date since its inception in 2003. The department receives samples from neighbouring countries such as Bangladesh and Nepal, as well as from across major Indian states, covering a wide spectrum of complex cancer diagnoses, including lymphoma, breast, soft tissue, gynaecological, bladder, prostate, lung, and gastrointestinal cancers. The upgraded department is equipped with advanced quality control measures and diagnostic protocols that will ensure accurate, prompt, and dependable results, which will facilitate better decision-making among healthcare providers.

In its continued efforts to leverage technology for better patient care, the hospital also introduced orthopaedic robot which will be a smart assistant to the surgeon and enhance accuracy, precision & patient outcomes. This version of robot that would be used for orthopaedic surgeries facilitates better implant positioning, decreased trauma, precise alignment, and faster recovery times for patients undergoing Unilateral Knee Replacement (UKR) and Total Hip Replacement (THR).

Highlighting the significance of these advancements, Dr Kunal Punamiya, CEO, S.L. Raheja Hospital, Mahim – A Fortis Associate, added, “Over 45years into our journey of delivering exceptional healthcare, these two launches underscore our commitment to enhancing patient experiences across the continuum of care: from diagnosis to treatment. The upgraded Histopathology Department will enable clinicians to make faster, more informed decisions, while our robotic-assisted orthopaedic surgery system will bring greater precision to surgical procedures. Through these advancements, we aim to deliver improved clinical outcomes and enhanced patient experiences.”

Dedicating this department to late Dr. Anita Borges, Dr Pravin Mahajan, HOD – Histopathology, S.L.  Raheja Hospital, Mahim – A Fortis Associate said, “As a centre of excellence since its inception, our Histopathology Department has built its reputation on a simple promise, accuracy, integrity, and trust. Over the years, it has been called upon across the country to provide second opinions in complex cases, reflecting the deep confidence clinicians place in its expertise. At its heart, however, this journey has always been about patients. Every diagnosis carries a responsibility, and every report a human story.”

The department at S.L. Raheja Hospital, Mahim has been further reinforced with a dedicated team of specialist doctors like Dr Maria Alina DeSouza, Consultant – Histopathologist & Dr Vivek Parameshwar, Consultant - Histopathologist, adding to its strong capability of diagnostics and clinical precision.

Commenting on the launch of the orthopedic robotic system, Dr. Lalit Panchal, Senior Consultant – Orthopedic Surgery, S.L. Raheja Hospital, Mahim - A Fortis Associate said, “Robotic-assisted surgery acts as an intelligent support to the surgeon, helping improve precision and surgical outcomes. It allows for better planning and execution of procedures. The system helps deliver safer, less invasive surgeries with natural results and faster recovery.”

The orthopaedic robotic programme at S.L. Raheja Hospital, Mahim is supported by a skilled surgical team, including Dr Vaibhav Kasodekar, Senior Consultant - Orthopaedic Surgeon & Dr Anoop Dhamangaonkar, Consultant - Joint Replacement and Orthopaedic Surgeon, who bring extensive experience in advanced joint replacement procedures.

With these launches, S.L. Raheja Hospital – A Fortis Associate reinforces its commitment to delivering quality healthcare, with a strong focus on outcomes, safety, and patient experience. 
 

About IHH Healthcare (“IHH”)
IHH is a leading multinational healthcare provider shaping the future of care. Driven by our aspiration to Care. For Good., we unite medical excellence and innovation, pushing boundaries through our trusted brands such as Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway and Prince Court. Across 10 countries, including Malaysia, Singapore, Türkiye, India and Greater China, our 70,000-strong team delivers world-class excellence every day, within and beyond our 140 healthcare facilities, including more than 80 hospitals. Our comprehensive services span the full healthcare continuum, from primary and ambulatory to quaternary care, complemented by diagnostics, imaging, rehabilitation, telehealth and home care. In partnership with our stakeholders, IHH is advancing value-based care, building a sustainable healthcare ecosystem and creating meaningful impact, as we work towards our vision to become the world’s most trusted healthcare services network. www.ihhhealthcare.com 

Left to Right : Dr Vinay Samuel Gaikwad, Senior Director Surgical Oncology, Dr Pooja Babbar, Consultant Medical Oncology, Dr Mansi Chowhan, Senior Consultant, Surgical Oncology

Fortis Cancer Institute, Manesar is backed by the latest healthcare infrastructure which includes Da Vinci Xi robotic surgery system, HIPEC (Hyperthermic Intraperitoneal Chemotherapy), PIPAC (Pressurized Intraperitoneal Aerosolized Chemotherapy), HAIP (Hepatic Artery Infusion Pump) chemotherapy, fluorescence-guided breast surgery, oncoplastic breast surgery, a dedicated lymphedema clinic, and organ-specific oncology programmes designed to deliver highly personalised treatment. The institute also places strong emphasis on precision oncology, supported by a multi-disciplinary tumor board, alongside newer treatment approaches such as immunotherapy, targeted therapy, molecular oncology, and genetic counseling and testing, enabling more tailored treatment decisions for complex cancer cases.

Speaking at the launch, Dr. Vinay Samuel Gaikwad, Senior Director, Surgical Oncology, Fortis Hospital, Manesar said, “The future of oncology lies in combining surgical precision with personalised treatment pathways. At Fortis Cancer Institute, our focus is on using advanced technologies to make cancer treatment more targeted, less invasive, and more effective for every patient.”

Dr. Pooja Babbar, Consultant, Medical Oncology, Fortis Hospital, Manesar said, “Cancer care today is no longer defined by a single treatment approach. By integrating molecular diagnostics, targeted therapies, and collaborative decision-making, we are creating a more comprehensive model of care that can improve both outcomes and quality of life.”

Dr. Mansi Chowhan, Senior Consultant, Surgical Oncology, Fortis Hospital, Manesar said, “What makes modern oncology different is the ability to treat each cancer uniquely. Through genetic testing, immunotherapy, and organ-specific expertise, we are able to design treatment strategies that are far more precise than conventional care.”

Abhijit Singh, Facility Director, Fortis Hospital Manesar, said, “The launch of the Fortis Cancer Institute at Manesar marks a significant step in our mission to bring world-class, advanced cancer care closer to patients in Manesar and surrounding regions. At a time when cancer cases are rising globally, there remains a critical gap in accessible, high-quality treatment. Fortis Cancer Institute, Manesar is designed to bridge this need, delivering cutting-edge technology, multidisciplinary expertise, and some of the finest oncologists to ensure comprehensive, patient-centric care.”

About Fortis Healthcare Limited 
Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics, and day care specialty facilities. Currently, the company operates 36 healthcare facilities (including JVs and O&M facilities) across 12 states and union territories. The Company’s network comprises over 6,000 operational beds (including O&M beds) and 400 diagnostics labs.

(R-L) Fortis Hospital Mulund’s Dr Moule, Dr Beri, Dr Saklani, Dr Akhade, Dr Dhabar, Dr S. Narayani, Dr Sharma and Ms Mavani at the screening of Molecules of Hope S2 at the hospital

The docuseries brings together compelling narratives at the intersection of science, innovation, and patient care, spotlighting medical institutions and caregivers driving meaningful transformation in healthcare. As part of a four-episode Season 2 lineup, Fortis Cancer Institute’s feature highlights its integrated OncoSciences ecosystem, clinical excellence, and patient-centric pathways that are redefining cancer care delivery in India, poising for greater global visibility through this recognition.

The feature captures the journeys of two cancer warriors; one treated for Breast Cancer (stage 4) and the other for Blood Cancer (Leukemia). It highlights how the patients, together with the dedicated team at the Fortis Cancer Institute, Fortis Hospital Mulund, navigated their treatment journeys with resilience and emerged cancer-free, returning to their families with renewed health & hope. The episode also features their clinical team, including Dr Avanish Saklani, Director – Surgical Oncology; Dr Boman Dhabar, Director – Medical Oncology; Dr Subhaprakash Sanyal, Director – Haemato-Oncology & BMT; Dr Arun Behl, Senior Consultant – Surgical Oncology; Dr Rupal Chheda, Consultant – Radiation Oncology; and Dr. Amol Akhade, Senior Consultant – Medical Oncology.

Dr. Pankaj Maheshwari, Senior Consultant – Urology, Dr Saurabh Patil, Senior Consultant – Urology, Dr Raj Kapadia, Consultant - Surgical Oncology, Dr Vivekanand Sharma, Consultant - Surgical Oncology, Dr Rathan Shetty, Consultant - Surgical Oncology, Dr. Deepanjali Adulkar, Consultant - Radiation Oncology, Dr. Pushkar Ingle, Consultant - Radiation Oncology have also made significant contributions towards the treatment of patients with cancer, and play a crucial role at the Fortis Cancer Institute.

Speaking about the feature, Dr. Vishal Beri, Facility Director, Fortis Hospital Mulund, Mumbai said, “Being featured on Molecules of Hope is a significant milestone for us. It showcases how innovation, clinical expertise, and compassionate care come together to transform cancer outcomes. At Fortis Mulund, we are committed to not just treating cancer but changing the way it is perceived by encouraging early detection, reducing stigma, and making advanced care more accessible - because today, hope really has a new story to tell.”

With cancer awareness days such as head & neck cancer, esophageal cancer, testicular cancer, observed in April, this feature comes at a critical time to drive conversations around early detection and timely intervention. Fortis Hospital Mulund’s Fortis Cancer Institute aims to leverage this platform to further engage the community, healthcare professionals, and stakeholders in building a more informed and proactive approach to cancer care.

Dr. S Narayani, Business Head – Fortis Hospitals, Maharashtra, said “The future of cancer care in India will be defined by how effectively we integrate innovation with accessibility. Platforms like ‘Molecules of Hope’ help bring this narrative to the forefront. At Fortis, we see ourselves contributing to this next phase by building comprehensive oncology models that prioritise early detection, precision-led treatment, and continuity of care. Our endeavour is to not only deliver clinical outcomes, but to help shape a more progressive and patient-centric cancer care ecosystem in the country. From Mumbai, we are proud to contribute to a larger narrative on how cancer care in India is evolving and how institutions like ours can help shape wider conversations around the future of OncoSciences.”

As part of this initiative, Fortis will roll out a series of engagement-led activities including community awareness programs, community screening initiatives (which have already reached 1lac households), collaborations with general practitioners, and knowledge-sharing platforms to extend the impact of this feature beyond the screen.

About IHH Healthcare (“IHH”)

IHH is a leading multinational healthcare provider shaping the future of care. Driven by our aspiration to Care. For Good., we unite medical excellence and innovation, pushing boundaries through our trusted brands such as Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway and Prince Court. Across 10 countries, including Malaysia, Singapore, Türkiye, India and Greater China, our 70,000-strong team delivers world-class excellence every day, within and beyond our 140 healthcare facilities, including more than 80 hospitals. Our comprehensive services span the full healthcare continuum, from primary and ambulatory to quaternary care, complemented by diagnostics, imaging, rehabilitation, telehealth and home care. In partnership with our stakeholders, IHH is advancing value-based care, building a sustainable healthcare ecosystem and creating meaningful impact, as we work towards our vision to become the world’s most trusted healthcare services network. www.ihhhealthcare.com

Jerome Le Jehan, Managing Director Consulting International, International SOS

Since the escalation of conflict, International SOS has been providing 24/7 on-the-ground support across the region, managing over 4,540 cases, supporting more than 1,390 client organisations, and coordinating the evacuation of over 1,370 people by land and air.

Through regular security briefing webinars and continuous alerts, International SOS has kept organisations informed and operationally prepared throughout the crisis.

What this sustained response has made clear is that operational readiness, while essential, is only part of the picture. Organisations across India many with significant workforce exposure across the Middle East are confronting a parallel and equally urgent challenge: the psychological toll of prolonged conflict on employees who may never set foot in a conflict zone yet carry the weight of uncertainty, anxiety, and disrupted focus every day.

Psychological Support Sessions is International SOS's direct response to this need, extending its crisis support model from the physical to the psychological, and enabling organisations to fulfil their Duty of Care in full.

“Organisations across India and the region are grappling with a reality that no wellness policy alone can address: their people are carrying the weight of sustained crisis - as employees, as parents, as human beings. Psychological Support Sessions exist to meet that need with clinical rigour and practical immediacy. This is not an add-on to Duty of Care; it is Duty of Care in action.”- Jerome Le Jehan, Managing Director Consulting International, International SOS.

Programme Overview
Psychological Support Sessions is delivered over six weeks, comprising six 30-minute expert-led sessions clinically designed and facilitated by qualified psychologists with direct experience in crisis environments. Sessions are recorded for ongoing access, making them practical for employees across time zones, seniority levels, and roles.

Core topics covered include:

• Regaining a sense of control in uncontrollable situations

• Managing information overload and constant news exposure

• Sleep disruption and recovery strategies

• Supporting parents, caregivers, and vulnerable family members

• Coping with prolonged uncertainty

• Managing the 'double load' of personal impact while supporting others

Designed for Organizations That Need:

• Practical wellbeing support for employees living in, deployed to, or psychologically impacted by the Middle East conflict

• A visible, proactive expression of Duty of Care that extends beyond operational security

• Structured support for employees, their families, and caregivers

• A credible, expert-led alternative to ad hoc wellbeing communications

• Guidance on managing stress, uncertainty, sleep disruption, and information overload at scale

Availability
Psychological Support Sessions is available immediately to organisations across India and South Asia. The programme is scalable for large, distributed workforces and can be deployed globally.

For enquiries or to schedule a consultation, please contact: info.india@internationalsos.com or visit www.internationalsos.com

About International SOS Group of Companies; 40 years of saving lives
The International SOS Group of Companies is in the business of protecting and saving lives. Wherever you are, we deliver customized security risk management, health and wellbeing solutions to fuel your growth and productivity. In the event of a security incident, epidemic, extreme weather or any other business-disrupting event, we provide an immediate response, giving you and your workforce peace of mind. We uniquely combine industry-leading technology with expertise in security, medical and logistics to deliver prevention programs that offer real-time, actionable insights and on-the-ground support.

Founded in 1985, the International SOS Group has been saving lives for 40 years. Headquartered in London and Singapore, we are trusted by over 9,000 organizations. This includes the majority of the Fortune Global 500, as well as mid-size enterprises, governments, educational institutions, and NGOs. Nearly 13,000 global experts stand with you to provide support and assistance from over 1,200 locations in 90 countries, over 110 languages, 24/7, 365 days a year.

Kauvery Hospital, Vadapalani
 

When the patient was brought to Kauvery Hospital, Vadapalani she was in critical condition. Investigations revealed a massive frontal brain tumour causing significant compression of surrounding structures. Despite limited margins for error due to her prolonged bedridden state, tracheostomy, and overall frailty, the surgical team, led by Dr. Ranganathan Jothi, performed a bifrontal craniotomy, surgical opening of the front skull to access both frontal lobes, and successfully removed the tumour in full. Post tumour removal, reconstruction of the skull base was carried out using the patient’s own tissue to minimise the risk of complications such as infection or cerebrospinal fluid leak.

In his comments, Dr. Ranganathan Jothi, Chief - Brain & Spine Surgeon, Director of Neurosciences, Kauvery Hospital, Vadapalani said, “Operating on a previously operated brain is itself a significant challenge. The procedure was further complicated by scar tissue, distorted anatomy, and the tumour’s proximity to critical brain structures and blood vessels, making it highly complex and demanding exceptional precision. Further complicating matters, the tumour’s size and the patient’s condition, having been bedridden for seven years with a tracheostomy, added further layers of complexity. However, leaving the tumour untreated was not an option. The patient responded well to the intervention, and such early recovery is particularly significant, marking a clear shift from her pre-surgical state and placing her on a positive path to rehabilitation.”

Dr Aravindan Selvaraj, Co-founder and Executive Director, Kauvery Group of Hospitals, commented, “This patient went beyond a complex tumour removal - it involved intervening in a patient who had been bedridden for seven years with very limited physiological reserve. Successfully managing a massive brain tumour in a previously operated, tracheostomy-dependent patient underscores the expertise, planning, and teamwork required in such high-risk scenarios. The intervention demonstrates that meaningful recovery is possible even in long-standing neurological disability when timely, precise surgical intervention is combined with coordinated critical care.”

Happiest Pearls Whitefield

The clinic offers a comprehensive range of services, including preventive and pediatric dentistry, restorative and prosthetic treatments, aligners, orthodontic treatment, dental implants, oral surgery, as well as laser-assisted procedures—ensuring atithis have access to holistic and specialized care within a single, integrated setting. Built with a strong focus on comfort, efficiency, and clinical precision, the facility integrates digital workflows and high-end equipment to deliver seamless care, from routine check-ups to advanced surgical procedures. The emphasis on stringent infection control, sterilization, and global asepsis protocols ensures a safe and reliable environment for atithis. The launch comes amid rising awareness around oral health and increasing demand for high-quality outpatient dental services in urban India, particularly in rapidly developing localities like Whitefield.

Dr. Vikram Shetty, BDS, MDS in Conservative Dentistry and Endodontics, Unit Head-Whitefield, Happiest Pearls, said, “As a clinician, my focus is on delivering precise, efficient, and comfortable treatments tailored to each atithi’s needs. This new facility allows us to combine advanced technology with a personalized approach, ensuring better outcomes and a significantly improved atithi experience.”

Dr. Achuth M. Baliga, Medical Director, Happiest Pearls, said, “At Happiest Pearls, we are committed to clinical excellence rooted in decades of experience. Our approach integrates surgical precision with long-term oral health outcomes, ensuring that every treatment is both functionally robust and aesthetically refined.”

Ashok Soota, Chairman & Chief Strategy Officer, Happiest Health, said, “At Happiest Health, we are focused on building a trusted healthcare network that combines compassion with cutting-edge innovation. The launch of our second dental clinic marks an important step in making world-class care more accessible.”

Davis Karedan, Co-Chairman & COO, Happiest Health, said, “With every new center, we are deepening our commitment to atithi-centric care and operational excellence. This clinic reflects our focus on quality, consistency, and creating a welcoming healthcare experience that atithi can trust.”

With this launch, Happiest Health continues to expand its integrated healthcare model, where oral health is positioned as a critical component of overall wellness. The company plans to further scale its dental network with additional clinics across India, reinforcing its commitment to accessible, high-quality healthcare delivery.

About Happiest Health

Happiest Health is an integrated “Healthcare & Wellness Enterprise” promoted by Ashok Soota. We are committed to improving health through better knowledge, state-of-the-art diagnostics, wellness centers, and clinics in a unique away-from-the-hospital model.

The business divisions of Happiest Health comprise Knowledge, Diagnostics, Healthcare Services and Wellness. The Knowledge business is already a global leader by virtue of its much-acclaimed Happiest Health magazine, free daily Healthzine, podcasts, videos, and impactful health summits. Diagnostics provides routine blood tests and specialized tests in Bangalore.

The Healthcare services (HCS) business specializes in multiple specialities. We currently offer Dental and Orthopaedic services. We will soon offer ENT, Ophthalmology, Paediatrics, Obesity & Weight management, Urology, and other disciplines.

The Wellness business too has a range of clinics including Ayurveda, Mental health, Body Dynamics, and Physiotherapy.

Our mission at Happiest Health is to inspire everyone to “embrace wellness” as a way of life.